UNITED STATES

 SECURITIES AND EXCHANGE COMMISSION

 WASHINGTON, D.C. 20549

 FORM 10-K

 ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 For the fiscal year ended December 31, 2023

 or

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 Commission file number 0-3722

 ATLANTIC AMERICAN CORP ORATION

 (Exact name of registrant as specified in its charter)

 Georgia

 58-1027114

 (State or other jurisdiction of incorporation or organization)

 (I.R.S. Employer Identification No.)

 4370 Peachtree Road, N.E.,

 Atlanta, Georgia

 30319

 (Address of principal executive offices)

 (Zip Code)

 (Registrant's telephone number, including area code) ( 404) 266-5500

 Securities registered pursuant to Section 12(b) of the Act:

 Title of each class

 Trading Symbol(s)

 Name of each exchange on which registered

 Common Stock, par value $1.00 per share

 AAME

 NASDAQ Global Market

 Securities registered pursuant to Section 12(g) of the Act:

 None

 Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes No

 Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes No

 Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the
 preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

 Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T
 (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes
 No

 Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging
 growth company. See definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act. (Check one):

 Large accelerated filer

 Accelerated filer

 Non-accelerated filer

 Smaller reporting company

 Emerging growth company

 If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised
 financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of internal control over
 financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements.

 Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period
 pursuant to §240.10D-1(b).

 Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

 The aggregate market value of common stock held by non-affiliates of the registrant as of June 30, 2023, the last business day of the registrant's most recently completed second fiscal
 quarter, was $ 7,887,231. For purposes hereof, beneficial ownership is determined under rules adopted pursuant to Section 13 of the
 Securities Exchange Act of 1934, and the foregoing excludes value ascribed to common stock that may be deemed beneficially owned by the directors and executive officers, and 10% or greater stockholders, of the registrant, some of whom may not be
 deemed to be affiliates upon judicial determination. On February 29, 2024, there were 20,402,288 shares of the registrant's common
 stock, par value $1.00 per share, outstanding.

 DOCUMENTS INCORPORATED BY REFERENCE

 Portions of the registrant's definitive
 Proxy Statement for the 2024 Annual Meeting of Shareholders, to be filed with the Securities and Exchange Commission within 120 days of the registrant's fiscal year end, have been incorporated by reference in Items 10, 11, 12, 13 and 14 of Part
 III of this Form 10-K.

 Page

 Forward-Looking Statements

 Item 1.

 Business

 The Company

 Marketing

 Underwriting

 Policyholder and Claims Services

 Competition

 Ratings

 Regulation

 NAIC Ratios

 Risk-Based Capital

 Human Capital

 Financial Information by Industry Segment

 Available Information

 Executive Officers of the Registrant

 Item 1A.

 Risk Factors

 Item 1B.

 Unresolved Staff Comments

 Item 1C.

 Cybersecurity

 Item 2.

 Properties

 Item 3.

 Legal Proceedings

 Item 4.

 Mine Safety Disclosures

 Item 5.

 Market for Registrant's Common Equity, Related Shareholder Matters and Issuer Purchases of Equity Securities

 Item 6.

 Reserved

 Item 7.

 Management's Discussion and Analysis of Financial Condition and Results of Operations

 Item 7A.

 Quantitative and Qualitative Disclosures About Market Risk

 Item 8.

 Financial Statements and Supplementary Data

 Item 9.

 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 Item 9A.

 Controls and Procedures

 Item 9B.

 Other Information

 Item 9C.

 Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 Item 10.

 Directors, Executive Officers and Corporate Governance

 Item 11.

 Executive Compensation

 Item 12.

 Security Ownership of Certain Beneficial Owners and Management and Related Shareholder Matters

 Item 13.

 Certain Relationships and Related Transactions, and Director Independence

 Item 14.

 Principal Accountant Fees and Services

 Item 15.

 Exhibits and Financial Statement Schedules

 Item 16.

 Form 10-K Summary

 Signatures

 Schedule II

 Schedule III

 Schedule IV

 Schedule VI

 FORWARD-LOOKING STATEMENTS

 Certain of the statements contained or incorporated by reference herein are forward-looking statements within the meaning of the federal securities laws. Forward-looking statements are all
 statements other than those of historical fact. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E
 of the Securities Exchange Act of 1934, and include estimates and assumptions related to, among other things, general economic, competitive, operational and legislative developments, expectations and trends. Forward-looking statements are
 inherently subject to risks and uncertainties which are, in many instances, beyond the Company's control and have been made based upon management's current expectations and beliefs concerning future developments and their potential effect upon
 the Company. There can be no assurance that future developments will be in accordance with management's expectations or that the effect of future developments on the Company will be those anticipated by management. Actual results could differ
 materially from those expressed by forward-looking statements, depending on the occurrence or outcome of various factors. These factors include, among others: the effects of macroeconomic conditions and general economic uncertainty; unexpected
 developments in the health care or insurance industries affecting providers or individuals, including the cost or availability of services, or the tax consequences related thereto; disruption to the financial markets; unanticipated increases in
 the rate, number and amounts of claims outstanding; our ability to remediate the identified material weakness in our internal control over financial reporting; the level of performance of reinsurance companies under reinsurance contracts and the
 availability, pricing and adequacy of reinsurance to protect the Company against losses; changes in the stock markets, interest rates or other financial markets, including the potential effect on the Company's statutory capital levels; the
 uncertain effect on the Company of regulatory and market-driven changes in practices relating to the payment of incentive compensation to brokers, agents and other producers; the potential impact of public health emergencies, such as COVID-19;
 the incidence and severity of catastrophes, both natural and man-made; the possible occurrence of terrorist attacks; stronger than anticipated competitive activity; unfavorable judicial or legislative developments; the potential effect of
 regulatory developments, including those which could increase the Company's business costs and required capital levels; the Company's ability to distribute its products through distribution channels, both current and future; the uncertain effect
 of emerging claim and coverage issues; the effect of assessments and other surcharges for guaranty funds and other mandatory pooling arrangements; information technology system failures or network disruptions; and risks related to cybersecurity
 matters, such as breaches of our computer network or those of other parties or the loss of or unauthorized access to the data we maintain. As a result, undue reliance should not be placed upon forward-looking statements, which speak only as of
 the date they are made. The Company undertakes no obligation to publicly update any forward-looking statements as a result of subsequent developments, changes in underlying assumptions or facts or otherwise, except as may be required by law.

 Item 1.

 Business

 The Company

 Atlantic American Corporation, a Georgia corporation incorporated in 1968 (the "Parent" or "Company"), is a holding company that operates through its subsidiaries in well-defined specialty
 markets within the life and health and property and casualty insurance industries. The Parent's principal operating subsidiaries are American Southern Insurance Company and American Safety Insurance Company (together known as "American Southern")
 within the property and casualty insurance industry and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (together known as "Bankers Fidelity") within the life and health
 insurance industry. Each of American Southern and Bankers Fidelity is managed separately based upon the type of products it offers and is evaluated on its individual performance. The Company's strategy is to focus on well-defined geographic,
 demographic and/or product niches within the insurance marketplace. Each of American Southern and Bankers Fidelity operates with relative autonomy, which structure is designed to allow for quick reaction to market opportunities.

 The Parent has no significant business operations of its own and relies on fees, dividends and other distributions from its operating subsidiaries as the principal source of cash flow to meet its
 obligations. Additional information regarding the cash flow and liquidity needs of the Parent can be found in the Liquidity and Capital Resources section of Management's Discussion and Analysis of Financial Condition and Results of Operations.

 American Southern comprises the Company's property and casualty operations and its primary product lines are as follows:

 Commercial Automobile Insurance policies provide bodily injury and/or property damage liability coverage, uninsured motorist coverage and physical damage coverage for commercial accounts.

 General Liability Insurance policies cover bodily injury and/or property damage liability for both premises and completed operations exposures for general classes of business.

 Surety Bonds are
 contracts under which one party, the insurance company issuing the surety bond, guarantees to a third party that the primary party will fulfill an obligation in accordance with a contractual agreement. This obligation may involve meeting a
 contractual commitment, paying a debt or performing certain duties.

 American Southern provides tailored commercial automobile insurance coverage, on a multi-year contract basis, to state governments, local municipalities and other large motor pools and fleets
 ("block accounts") that can be specifically rated and underwritten. The size of the block accounts insured by American Southern are generally such that individual class experience can be determined, which allows for customized policy terms and
 rates. American Southern is licensed to do business in 32 states and the District of Columbia. While the majority of American Southern's premiums are derived from its automobile lines of business, American Southern also offers general liability
 and other lines such as inland marine coverage. Additionally, American Southern directly provides surety bond coverage for subdivision construction, school bus contracts, as well as performance and payment bonds.

 The following table summarizes, for the periods indicated, the allocation of American Southern's net earned premiums from each of its principal product lines:

 2023

 2022

 Automobile liability

 $

 38,821

 $

 33,981

 Automobile physical damage

 15,046

 21,069

 General liability

 5,758

 5,871

 6,303

 6,039

 Other lines

 2,515

 3,316

 Total

 $

 $

 Bankers Fidelity comprises the life and health operations of the Company and offers a variety of life and supplemental health products. Products offered by Bankers Fidelity include ordinary life
 insurance, Medicare supplement and other accident and health insurance products.

 Life Insurance products
 include non-participating, individual and group whole life insurance policies with a variety of riders and options. Policy premiums are dependent upon a number of factors, including issue age, level of coverage and selected riders or options.

 Medicare Supplement Insurance includes 8 of the 10 standardized Medicare supplement policies created under the Medicare Improvements for Patients and Providers Act of 2008 ("MIPPA"), which are designed to provide insurance coverage for certain expenses not covered
 by the Medicare program, including copayments and deductibles.

 Other Accident and Health Insurance coverages include several individual and group policies providing for the payment of standard benefits in connection with the treatment of diagnosed cancer and other critical illnesses, as well as a number of other policies
 providing short-term nursing facility care, accident only, hospital indemnity and disability coverages.

 Health insurance products, primarily Medicare supplement insurance, accounted for 83% of Bankers Fidelity's net earned premiums in 2023 while life insurance, including both whole and term life
 insurance policies, accounted for the balance. In terms of the number of policies written in 2023, 63% were health insurance policies and 37% were life insurance policies.

 The following table summarizes, for the periods indicated, the allocation of Bankers Fidelity's net earned premiums from each of its principal product lines:

 2023

 2022

 Life insurance

 $

 18,584

 $

 15,805

 Medicare supplement

 77,425

 86,970

 Other accident and health

 14,373

 12,389

 Total health insurance

 91,798

 99,359

 Total

 $

 $

 Marketing

 A portion of American Southern's business is marketed through a small number of specialized, experienced independent agents. American Southern's agent selection process is actively managed by
 internal marketing personnel with oversight from management. Senior management carefully reviews all new programs prior to acceptance. American Southern solicits business through multiple channels. Most of American Southern's agents are paid an
 up-front commission with the potential for additional commissions by participating in a profit sharing arrangement that is directly linked to the profitability of the underlying business. American Southern also solicits business from governmental
 entities. As an experienced writer of insurance policies for certain governmental programs, the company actively pursues this market on a direct basis. Much of this business is priced by means of competitive bid situations. As a result, there can
 be no assurance with respect to the ultimate profitability or ability of the Company to obtain or retain such business at the time of a specific contract renewal.

 Bankers Fidelity acquires its clientele through three distribution channels spread across 46 different states and two business divisions, all of which utilize commissioned, independent agents.
 The three distribution channels include traditional independent agents, brokers typically interested in a specific product of Bankers Fidelity and brokers who focus on sales within the group/employer benefits division, Atlantic American Employee
 Benefits, all of which are responsible for their own marketing and sales activities. Contracting as independent agents enables Bankers Fidelity to effectively expand or contract its sales force without incurring significant expense.

 Bankers Fidelity had approximately 4,639 licensed agents contracted in both the individual and group divisions as of December 31, 2023. During 2023, approximately 454 of these licensed agents
 wrote policies on behalf of Bankers Fidelity.

 Bankers Fidelity's marketing and distribution strategy revolves around five pillars: Diversification, Differentiation, Quality, Retention and Profitability.

 Diversification. Through unique
 product offerings such as the Vantage Flex Plus, a hospital indemnity plan, and Vantage Recovery, short-term care product and a group whole life product featuring a chronic illness rider, the Company is able to offer its distributors an array
 of products to sell that stand out from the competition. As the Company continues to expand its geographical footprint with agents and products, one of its main objectives is to have a healthy mix of all of its product lines nationwide.

 Differentiation. Bankers
 Fidelity prides itself on the quality of customer service it offers to policyholders and agents. A dedicated agent support team is available to the field to support them on administration, underwriting, sales training, product questions and a
 plethora of other services which differentiates the Company from other carriers. Additionally, a customer loyalty team is available solely to serve insureds for any of their insurance needs. Bankers Fidelity prides itself on being agile, which
 we believe differentiates us from larger carriers and helps the Company to quickly execute senior management's initiatives.

 Quality. Bankers Fidelity is
 focused on being a niche carrier that delivers superior service, quality products and innovative solutions. Sophisticated technology and reporting allows the home office teams to work with the sales force to deliver a tailored experience and
 phenomenal customer service.

 Retention. Through seasonal
 campaigns and customer outreach, the Company is focused on client retention and servicing its policyholders through all stages in their lives. By providing its agents with an innovative product portfolio, the Company further promotes client
 retention by empowering its agents to continually meet the needs of our policyholders.

 Profitability. In an effort to
 be sustainable in the marketplace as a long-term partner, senior management is focused on diversification, differentiation, quality and retention to achieve profitability.

 Underwriting

 American Southern specializes in underwriting various risks that are sufficiently large enough to establish separate class experience, relying upon the underwriting expertise of its agents.

 During the course of the policy life, extensive use is made of risk management representatives to assist commercial underwriters in identifying and correcting potential loss exposures and to
 physically inspect new accounts. The underwriting results from each insured are reviewed on an individual basis periodically. If results are below expectations, management takes corrective action, which may include adjusting rates, revising
 underwriting standards, adjusting commissions paid to agents, and/or altering or declining to renew accounts at expiration.

 Bankers Fidelity issues a variety of products that span from the group markets to the individual markets for both life and health insurance. Products offered by Bankers Fidelity include life
 insurance, typically with small face amounts, Medicare supplement and other accident and health insurance. Bankers Fidelity also provides an array of group products such as accident, cancer, critical illness, hospital indemnity and life insurance
 that is offered to employers who are looking to provide coverage for their employees and have the related premiums deducted through payroll deductions.

 The individual products are underwritten on a non-medical basis using a simplified issue approach by which an application containing a variety of health related questions is submitted.
 Applications for insurance are reviewed to determine the face amount, age, medical history and any other necessary information. Bankers Fidelity utilizes information obtained directly from the insured, the medical claims data, prescription
 utilization reports as well as telephone interviews to determine whether an applicant meets the Company's underwriting criteria. Bankers Fidelity may also utilize medical records and investigative services to supplement and substantiate
 information, as necessary.

 The group products are underwritten and assessed at the group level for financial risk. The underwriting will utilize several factors to determine this risk such as the industry, demographics, enrollment strategies,
 employee access, locations of offices and any regulatory or legislative changes that could impact the decisions. The spread of risk is also reviewed which analyzes the content of the employees within the group which includes the spread of gender,
 ages, salaries and occupations. This information is used to quote an appropriate benefits package, pricing, waiting periods and rates for the group entity.

 Policyholder and Claims Services

 The Company believes that prompt, efficient policyholder and claims services are essential to its continued success in marketing its insurance products (see "Competition"). Additionally, the
 Company believes that its insureds are particularly sensitive to claims processing time and to the accessibility of qualified staff to answer inquiries. Accordingly, the Company's policyholder and claims services seek to offer expeditious
 disposition of service requests by providing toll-free access for all customers, 24-hour claim reporting services, and direct computer links with some of its largest accounts. The Company also utilizes an automatic call distribution system
 designed to ensure that inbound calls to customer service support groups are processed efficiently. Operational data generated from this system allows management to further refine ongoing client service programs and service representative
 training modules.

 American Southern controls its claims costs by utilizing an in-house staff of claims supervisors to investigate, verify, negotiate and settle claims. Upon notification of an occurrence
 purportedly giving rise to a claim, a claim file is established. The claims department then conducts a preliminary investigation, determines whether an insurable event has occurred and, if so, updates the file for the findings and any required
 reserve adjustments. Independent adjusters and appraisers are frequently utilized to service claims which require on-site inspections.

 The majority of life and health claims are filed electronically while insureds also have the ability to download claims forms and file directly. Insureds may also obtain claim forms by calling
 the customer service group or through Bankers Fidelity's website. All of these claims are entered into the system immediately upon receipt and put into a pending status until the claim can be fully processed. To shorten claim processing time, a
 letter detailing all supporting documents that are required to complete a claim for a particular policy is sent to the customer along with the correct claim form. Properly documented claims are generally paid within five business days of receipt.
 With regard to Medicare supplement policies, the claim is either directly billed to Bankers Fidelity by the provider or sent electronically through a Medicare clearing house.

 Reserves are set by line of business within each of the subsidiaries. At December 31, 2023, approximately 73% of the losses and claims reserves related to property and casualty and approximately
 27% related to life and health. The Company's property and casualty operations incur losses which may take extended periods of time to evaluate and settle. Issues with respect to legal liability, actual loss quantification, legal discovery and
 ultimate subrogation, among other factors, may influence the initial and subsequent estimates of loss. In the property and casualty operations, the Company's general practice is to reserve at the higher end of the determined reasonable range of
 loss if no other value within the range is determined to be more probable. The Company's life and health operations generally incur losses which are more readily quantified. Medical claims received are recorded in case reserves based on
 contractual terms using the submitted billings as a basis for determination. Life claims are recorded based on contract value at the time of notification to the Company; offset by policy reserves related to such contracts previously established.
 Individual case reserves are established by a claims processor on each individual claim and are periodically reviewed and adjusted as new information becomes known during the course of handling a claim. Regular internal periodic reviews are also
 performed by management to ensure that loss reserves are established and revised timely relative to the receipt of new or additional information. Lines of business for which loss data (e.g. paid losses and case reserves) emerge over a long period
 of time are referred to as long-tail lines of business. Lines of business for which loss data emerge more quickly are referred to as short-tail lines of business. The Company's long-tail line of business generally consists of its general
 liability coverage while the short-tail lines of business generally consist of property and automobile coverages.

 The Company's actuaries regularly review reserves for both current and prior accident years using the most current claims data. These reviews incorporate a variety of actuarial methods (discussed
 in Critical Accounting Policies) and judgments and involve a disciplined analysis. For most lines of business, certain actuarial methods and specific assumptions are deemed more appropriate based on the current circumstances affecting that line
 of business. These selections incorporate input from claims personnel and operating management on reported loss cost trends and other factors that could affect the reserve estimates.

 The Company establishes reserves for claims based upon: (a) management's estimate of ultimate liability and claims adjusters' evaluations of unpaid claims reported prior to the close of the
 accounting period, (b) estimates of incurred but not reported ("IBNR") claims based on past experience, and (c) estimates of losses and loss adjustment expense ("LAE"). The estimated liability is periodically reviewed and updated, and changes to
 the estimated liability are recorded in the statement of operations in the period in which such changes become known.

 For long-tail lines of business, the emergence of paid losses and case reserves is less credible in the early periods, and accordingly may not be indicative of ultimate losses. For these lines,
 methods which incorporate a development pattern assumption are given less weight in calculating IBNR for the early periods of loss emergence because such a low percentage of ultimate losses are reported in that time frame. Accordingly, for any
 given accident year, the rate at which losses on long-tail lines of business emerge in the early periods is generally not as reliable an indication of ultimate losses as it would be for shorter-tail lines of business. The estimation of reserves
 for these lines of business in the early periods of loss emergence is therefore largely influenced by statistical analyses and application of prior accident years' loss ratios, after considering changes to earned pricing, loss costs, mix of
 business, ceded reinsurance and other factors that are expected to affect the estimated ultimate losses. For later periods of loss emergence, methods which incorporate a development pattern assumption are given more weight in estimating ultimate
 losses. For short-tail lines of business, the emergence of paid loss and case reserves is more credible in the early periods and is more likely to be indicative of ultimate losses. The method used to set reserves for these lines of business is
 based upon utilization of a historical development pattern for reported losses. IBNR reserves for the current year are set as the difference between the estimated fully developed ultimate losses for each year, less the established, related case
 reserves and cumulative related payments. IBNR reserves for prior accident years are similarly determined, again relying on an indicated, historical development pattern for reported losses.

 Based on the results of regular reserve estimate reviews, the Company determines the appropriate reserve adjustment, if any, to record in each period. If necessary, recorded reserve estimates are
 changed after consideration of numerous factors, including, but not limited to, the magnitude of the difference between the actuarial indication and the recorded reserves, improvement or deterioration of actuarial indication in the period, the
 maturity of the accident year, trends observed over the recent past and the level of volatility within a particular line of business. In general, changes are made more quickly to recognize changes in estimates to ultimate losses in mature
 accident years and less volatile lines of business.

 The Company's policy is to record reserves for losses and claims in amounts that represent actuarial best estimates of ultimate values. Actuarial best estimates do not necessarily represent the
 midpoint value determined using the various actuarial methods; however, such estimates will fall between the estimated low and high end reserve values. The range of estimates developed in connection with the December 31, 2023 actuarial review
 indicated that reserves could be as much as 16.9% lower or as much as 18.3% higher. In the opinion of management, recorded reserves represent the best estimate of outstanding losses, although significant judgments are made in the derivation of
 reserve estimates and revisions to such estimates are expected to be made in future periods. Any such revisions could be material, and may materially adversely affect the Company's financial condition and results of operations in any future
 period.

 American Southern maintains loss reserves representing estimates of amounts necessary for payment of losses and LAE, which are not discounted. IBNR reserves are also maintained for future
 development. These loss reserves are estimates, based on known facts and circumstances at a given date, of amounts the Company expects to pay on incurred claims. All balances are reviewed periodically by the Company's independent consulting
 actuary. Reserves for LAE are intended to cover the ultimate costs of settling claims, including investigation and defense of any lawsuits resulting from such claims. Loss reserves for reported claims are based on a case-by-case evaluation of the
 type of claim involved, the circumstances surrounding the claim, and the policy provisions relating to the type of loss along with anticipated future development. The LAE for claims reported and claims not reported is based on historical
 statistical data and anticipated future development. Inflation and other factors which may affect claim payments are implicitly reflected in the reserving process through analysis and consideration of cost trends and reviews of historical reserve
 results.

 Estimating case reserves and ultimate losses involves various considerations which differ according to the line of business. In addition, changes in legislative and regulatory environments may
 impact loss estimates. General liability claims may have a long pattern of loss emergence. Given the broad nature of potential general liability coverages, investigative time periods may be extended and questions of coverage may exist. Such
 uncertainties create greater imprecision in estimating required levels of loss reserves. The property and automobile lines of business generally have less variable reserve estimates than other lines. This is largely due to the coverages having
 relatively shorter periods of loss emergence. Estimates, however, can still vary due to a number of factors, including interpretations of frequency and severity trends. Severity trends can be impacted by changes in internal claim handling and
 reserving practices in addition to changes in the external environment. These changes in claim practices increase the uncertainty in the interpretation of case reserve data, which increases the uncertainty in recorded reserve levels.

 Bankers Fidelity establishes reserves for future policy benefits to meet projected obligations under policies that are in force as of the statement date. These reserves are calculated to satisfy
 policy and contract obligations as they are projected to come due. Reserves for insurance policies are calculated using assumptions for interest rates, mortality rates, disablement rates, benefit utilization rates, and lapse rates. These
 assumptions vary by the product type, the year the policy was issued, and certain policyholder demographic information. Changes in assumptions may be made from one issue year to another to reflect actual experience. Actual future experience
 that deviates significantly from the assumptions, or actual results that differ significantly from our estimates, could have a materially adverse effect on our liquidity, results of operations, or financial condition.

 See Note 6 of Notes to Consolidated Financial Statements for more information on insurance reserves and policyholder funds.

 The Company's insurance subsidiaries from time to time purchase reinsurance from unaffiliated insurers and reinsurers to reduce their potential liability on individual risks and to protect
 against catastrophic losses. In a reinsurance transaction, an insurance company transfers, or "cedes," a portion or all of its exposure on insurance policies to a reinsurer. The reinsurer assumes the exposure in return for a portion of the
 premiums. The ceding of insurance does not legally discharge the insurer from primary liability for the full amount of the policies written by it, and the ceding company will incur a loss if the reinsurer fails to meet its obligations under the
 reinsurance agreement.

 American Southern's basic reinsurance treaties generally cover all claims in excess of specified per occurrence limitations. Current limits per occurrence within the reinsurance treaties are as
 follows: Inland marine and commercial automobile physical damage - $225,000 excess of $125,000 retention; and automobile liability and general liability - excess coverage of $2.0 million less retentions that may vary from $150,000 to $500,000
 depending on the account. American Southern maintains a property catastrophe treaty with a $5.5 million limit excess of $500,000 retention. American Southern also issues individual surety bonds with face amounts generally up to $1.5 million, and
 limited to $5.0 million in aggregate per account, that are not reinsured.

 Bankers Fidelity has entered into reinsurance contracts ceding the excess of its life retention. Maximum retention by Bankers Fidelity on any one individual life insurance policyholder is
 $200,000. As of December 31, 2023, $8.3 million of the $814.2 million of life insurance in force at Bankers Fidelity was reinsured under a combination of coinsurance and yearly renewable term agreements. Certain prior year reinsurance agreements
 also remain in force although they no longer provide reinsurance for new business.

 Bankers Fidelity has also entered into a reinsurance contract ceding excess new Medicare Supplement business to General Re Life Corporation. Ceding thresholds are set annually. During 2023, the
 liability of the reinsurer was 50% of all new Medicare Supplement business issued by the Company on amounts up to a maximum retention of $15.0 million of annualized premium. Accordingly, $0.8 million of the Company's $1.5 million of new
 annualized Medicare Supplement premium was ceded.

 Competition

 Competition for insurance products is based on many factors including premiums charged, terms and conditions of coverage, customer service, financial ratings assigned by independent rating
 agencies, claims handling, consumer recognition and reputation, perceived financial strength and the experience of the organization in the line of business being written.

 The businesses in which American Southern engages are highly competitive. The principal areas of competition are pricing and service. Many competing property and casualty companies have been in
 business longer than American Southern, offer more diversified lines of insurance and have substantially greater financial resources. Management believes, however, that the policies it sells are competitive with those providing similar benefits
 offered by other insurers doing business in the states in which American Southern operates. American Southern strives to develop strong relationships with its agents and, consequently, believes it is well positioned for new opportunities and
 programs with those agents.

 The life and health insurance business remains highly competitive and includes a large number of insurance companies, many of which are new entrants to the business of providing Medicare
 supplement and other accident and health insurance products. Bankers Fidelity has established itself as a trusted carrier of choice for its customers providing quality and sustainability for over 65 years.

 In order to compete, Bankers Fidelity actively seeks opportunities in niche markets, developing long-term relationships with a select number of independent marketing organizations. Additionally,
 Bankers Fidelity actively promotes Atlantic American Employee Benefits, the group benefits division, as well as selective association partnerships. It competes with other insurers to attract and retain the allegiance of its independent agents
 through commission and sales incentive arrangements, accessibility and marketing assistance, lead programs, reputation and market expertise. Bankers Fidelity successfully competes in its chosen markets by establishing relationships with
 independent agents and providing proprietary marketing initiatives as well as providing outstanding service to policyholders.

 Ratings

 Ratings are important measures within the insurance industry, and higher ratings are expected to have a favorable impact on the ability of a company to compete in the marketplace. Ratings of
 insurance companies are not designed for investors and do not constitute recommendations to buy, sell, or hold any security.

 Each year A.M. Best Company, Inc. ("A.M. Best") publishes Best's Insurance Reports, which includes assessments and ratings of all insurance companies. A.M. Best's financial strength ratings,
 which may be revised or revoked at any time, follow a graduated scale of rating categories and notches ranging from A++ (Superior) to F (in liquidation). A.M. Best's ratings are based on a detailed analysis of the statutory financial condition
 and operations of an insurance company compared to the industry in general.

 American Southern. American
 Southern Insurance Company and its wholly-owned subsidiary, American Safety Insurance Company, are each, as of the date of this report, rated "A" (Excellent) by A.M. Best.

 Bankers Fidelity. Bankers
 Fidelity Life Insurance Company and its wholly-owned subsidiary, Bankers Fidelity Assurance Company, are each, as of the date of this report, rated "A-" (Excellent) by A.M. Best.

 Regulation

 Like all domestic insurance companies, the Company's insurance subsidiaries are subject to regulation and supervision in the jurisdictions in which they do business. Statutes typically delegate
 regulatory, supervisory, and administrative powers to state insurance commissioners. The method of such regulation varies, but regulation relates generally to the licensing of insurers and their agents, the nature of and limitations on
 investments, approval of policy forms, reserve requirements, the standards of solvency to be met and maintained, deposits of securities for the benefit of policyholders, and periodic examinations of insurers and trade practices, among other
 things. The Company's products generally are subject to rate regulation by state insurance commissions, which require that certain minimum loss ratios be maintained. Certain states also have insurance holding company laws which require
 registration and periodic reporting by insurance companies controlled by other corporations licensed to transact business within their respective jurisdictions. The Company's insurance subsidiaries are subject to such legislation and are
 registered as controlled insurers in those jurisdictions in which such registration is required. Such laws vary from state to state, but typically require periodic disclosure concerning the corporation which controls the registered insurers and
 all subsidiaries of such corporations, as well as prior notice to, or approval by, the state insurance commissioners of intercorporate transfers of assets (including payments of dividends by the insurance subsidiaries in excess of specified
 amounts) within the holding company system. The Company believes it is in compliance with all such requirements.

 Most states require that rate schedules and other information be filed with the state's insurance regulatory authority, either directly or through a ratings organization with which the insurer is
 affiliated. The regulatory authority may disapprove a rate filing if it determines that the rates are inadequate, excessive, or discriminatory. The Company has historically experienced no significant regulatory resistance to its applications for
 rate adjustments; however, the Company cannot provide any assurance that it will not receive any objections to any applications in the future.

 A state may require that acceptable securities be deposited for the protection either of policyholders located in those states or of all policyholders. As of December 31, 2023, the Company was in
 compliance with all such requirements, and securities with an amortized cost of $14.6 million were on deposit either directly with various state authorities or with third parties pursuant to various custodial agreements on behalf of the Company's
 insurance subsidiaries.

 Virtually all of the states in which the Company's insurance subsidiaries are licensed to transact business require participation in their respective guaranty funds designed to cover claims
 against insolvent insurers. Insurers authorized to transact business in these jurisdictions are generally subject to assessments of up to 4% of annual direct premiums written in that jurisdiction to pay such claims, if any. The likelihood and
 amount of any future assessments cannot be estimated until an insolvency has occurred.

 NAIC Ratios

 The National Association of Insurance Commissioners (the "NAIC") was established to, among other things, provide guidelines to assess the financial strength of insurance companies for state
 regulatory purposes. The NAIC conducts annual reviews of the financial data of insurance companies primarily through the application of financial ratios prepared on a statutory basis. Annual statements are required to be submitted to state
 insurance departments to assist them in monitoring insurance companies in their state and to allow such states to determine a desirable range for each such ratio with which companies should comply.

 The NAIC developed the Insurance Regulatory Information System ("IRIS") to help state regulators identify companies that may require regulatory attention. Financial examiners review annual
 financial statements and the results of key financial ratios based on year-end data with the goal of identifying insurers that appear to require immediate regulatory attention. Each ratio has an established "usual range" of results. A ratio
 result falling outside the usual range, however, is not necessarily considered adverse; rather, unusual values are used as part of the regulatory early monitoring system. Furthermore, in some years, it may not be unusual for financially sound
 companies to have several ratios with results outside the usual ranges. Generally, an insurance company may become subject to regulatory scrutiny or, depending on the company's financial condition, regulatory action if certain of its key IRIS
 ratios fall outside the usual ranges and the insurer's financial condition is trending downward.

 For the year ended December 31, 2023, Bankers Fidelity Assurance Company had three ratios outside the usual range, primarily as a result of net loss for the year, certain surplus ratios and
 Non-admitted Assets to Admitted Assets. The net loss at Bankers Fidelity Assurance Company is primarily related to federal income taxes incurred which resulted in a corresponding decrease in surplus levels for the year as well as a growing
 Deferred Tax Asset which is a Non-admitted. Atlantic Capital Life Assurance Company had one ratio outside the normal range, Change in Asset Mix. The Change in Asset Mix was the result of Atlantic Capital Life Assurance Company investing its
 cash and cash equivalents from prior year into bonds. Bankers Fidelity Life Insurance Company, American Southern Insurance Company and American Safety Insurance Company had no IRIS ratios outside the usual ranges. Management does not anticipate
 regulatory action as a result of the 2023 IRIS ratio results for the insurance subsidiaries.

 Risk-Based Capital

 Risk-based capital ("RBC") is a metric used by ratings agencies and regulators as an early warning tool to identify weakly capitalized companies for the purpose of initiating further regulatory
 action. The RBC calculation determines the amount of adjusted capital needed by a company to avoid regulatory action. "Authorized Control Level Risk-Based Capital" ("ACL") is calculated, and if a company's adjusted capital is 200% or lower than
 ACL, it is subject to regulatory action. At December 31, 2023, the Company's insurance subsidiaries' RBC levels exceeded the required regulatory levels.

 Investment income represents a significant portion of the Company's operating and total income. Insurance company investments are subject to state insurance laws and regulations which limit the
 concentration and types of investments. The following table provides information on the Company's investments as of the dates indicated.

 December 31,

 2023

 2022

 Percent

 Percent

 Fixed maturities:

 U.S. Treasury securities and obligations of U.S. Government agencies and authorities

 $

 50,059

 21.1

 %

 $

 44,412

 19.4

 %

 States, municipalities and political subdivisions

 8,106

 3.4

 9,187

 4.1

 Public utilities

 9,530

 4.0

 10,284

 4.5

 All other corporate bonds

 150,319

 63.4

 144,623

 63.2

 Redeemable preferred stock

 0.1

 0.1

 Total fixed maturities (1)

 92.0

 91.3

 Equity securities (2)

 9,413

 4.0

 5.0

 Other invested assets (3)

 6,381

 2.8

 5,386

 2.4

 Policy loans (4)

 1,778

 0.7

 1,759

 0.8

 Real estate

 0.0

 0.0

 Investments in unconsolidated trusts

 1,238

 0.5

 1,238

 0.5

 Total investments

 $

 237,067

 100.0

 %

 $

 228,712

 100.0

 %

 (1)

 Fixed maturities are carried on the balance sheet at estimated fair value. Certain fixed maturities do not have publicly quoted prices, and are carried at estimated fair value as determined by management. Total amortized cost of fixed
 maturities was $238.6 million as of December 31, 2023 and $236.8 million as of December 31, 2022.

 (2)

 Equity securities are carried on the balance sheet at estimated fair value. Total cost of equity securities was $4.9 million as of December 31, 2023 and 2022.

 (3)

 Other invested assets are accounted for using the equity method. Total cost of other invested assets was $7.0 million as of December 31, 2023 and $5.6 million as of December 31, 2022.

 (4)

 Policy loans are valued at unpaid principal balances.

 Estimated fair values are determined as discussed in Note 1 of Notes to Consolidated Financial Statements.

 Results of the Company's investment portfolio for periods shown were as follows:

 2023

 2022

 Average investments (1)

 $

 275,995

 $

 270,636

 Net investment income

 9,932

 Average yield on investments

 3.6

 %

 3.7

 %

 (1)

 Calculated as the average of cash and investment balances (at amortized cost) at the beginning of the year and at the end of each of the succeeding four quarters.

 The Company engages a global investment management firm serving the insurance industry to manage the Company's investment portfolios. Management's recent investment strategy has been a continued
 focus on quality and diversification, while improving the overall risk versus return profile of the portfolio.

 Human Capital

 The Company and its subsidiaries employed 155 people at December 31, 2023. Of the 155 people, 154 were full-time. We believe that our ability to attract and retain highly motivated and skilled
 employees with diverse backgrounds and experiences is critical to our continued success. We also believe the structure of our compensation program is aligned with the interests of our shareholders and serves to reward the performance of our
 employees. We monitor and evaluate the effectiveness of our human capital management efforts by seeking formal and informal feedback from our employees, including periodic surveys to obtain opinions on key topics.

 We sponsor health and wellness programs in an effort to promote a healthier employee base. We also offer competitive health and wellbeing benefits to include health, dental, vision, health and
 flexible savings accounts, disability, life, supplemental and telemedicine. An Employee Assistance Program ("EAP") is provided to all full-time employees and their family members at no cost. The EAP offers confidential telephonic counseling,
 referral services, legal and financial services and additional tools that offer support and solutions. Additionally, we offer a 401(k) retirement savings plan with an employer match as well as an annual Safe Harbor Non-Elective contribution.

 We strive to provide a work environment that encourages work/life balance. Options depend on job responsibilities and may include flexible work schedules, paid time off, paid holidays and part-time employment.

 We offer tuition reimbursement along with budgeted professional development opportunities in order to foster professional growth and to increase skillsets.

 Financial Information by Industry Segment

 American Southern and Bankers Fidelity each operate with relative autonomy and each company is evaluated on its individual performance. American Southern operates in the property and casualty
 insurance market, while Bankers Fidelity operates in the life and health insurance market. Each segment derives revenue from the collection of premiums, as well as from investment income. Substantially all revenue other than that in the corporate
 and other segment is from external sources. For more information on segments, see Note 16 of Notes to Consolidated Financial Statements.

 Available Information

 The Company files annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, amendments to those reports and other information with the Securities and Exchange
 Commission (the "SEC"). The SEC maintains a website at www.sec.gov that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC, including the Company. In addition, as soon
 as reasonably practicable after such materials are filed with or furnished to the SEC by the Company, the Company makes copies available to the public, free of charge, on or through its web site at www.atlam.com. Neither the Company's website,
 nor the information appearing on the website, is included, incorporated into, or a part of, this report.

 Executive Officers of the Registrant

 The table and information below set forth, for each current executive officer of the Company, his name, age (as of March 1, 2024), positions with the Company and business experience for the past
 five years, as well as any prior service to the Company.

 Name

 Age

 Positions with the Company

 Director or Officer Since

 Hilton H. Howell, Jr.

 Chairman of the Board, President & CEO

 1992

 J. Ross Franklin

 Vice President, CFO and Corporate Secretary

 2017

 Officers are elected annually and serve at the discretion of the board of directors.

 Mr. Howell has been President
 and Chief Executive Officer of the Company since May 1995, and prior thereto served as Executive Vice President of the Company from October 1992 to May 1995. He has been a Director of the Company since October 1992 and effective February 24,
 2009, began serving as Chairman of the board of directors. He is also Executive Chairman and Chief Executive Officer of Gray Television, Inc.

 Mr. Franklin has been Vice
 President, Chief Financial Officer and Corporate Secretary of the Company since November 2017, and prior thereto served as Interim Chief Financial Officer from August 2017 to November 2017. Since 2000 he has held various roles of increasing
 responsibility with Atlantic American and its subsidiaries, previously serving as Vice President, Accounting and Treasurer of Bankers Fidelity since 2009.

 Item 1A.

 Risk Factors

 As a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and in Item 10(f)(1) of Regulation S-K (a "smaller reporting company"), we have elected to comply with certain scaled
 disclosure reporting obligations, and therefore are not providing the information required by this Item.

 Item 1B.

 Unresolved Staff Comments

 Not applicable.

 Item 1C.

 Cybersecurity

 Risk Management and Strategy

 The Company's operations rely on the secure processing, storage, and transmission of confidential and personal identifiable information within various technology platforms. Cybersecurity is a
 high priority and the Company has made significant investments in its processes and programs designed to prevent, detect, and respond to and recover from cybersecurity threats. We also have processes in place to help ensure compliance with our
 information security program with respect to our use of third-party service providers. Such processes and programs are a part of the Company's overall risk management and compliance programs. The Company continues to enhance its intrusion
 protection and detection technology, infrastructure and application firewalls, and network monitoring. The Company has also installed advanced endpoint threat protection technology and implemented a mandatory security awareness training program
 for all employees. This training is reinforced through periodic simulated phishing tests to assess our employees' responses to suspicious emails.

 The Company uses a sophisticated backup and recovery methodology that supports the replication of data across multiple secure data centers. It also includes a comprehensive disaster recovery plan
 that is continually tested and designed to help enable us to resume business in the event of a disaster or cybersecurity incident. Through recurring internal and external audits, controls are regularly reviewed, tested, and enhanced to promote
 best practices. The Company has augmented our information security program through a partnership with a leading global cybersecurity service provider to review and implement additional services such as Security Event Monitoring, Advanced Endpoint
 Threat Detection, Incident Management Retainer Services, and Strategic Advisory Services focused on Chief Information Security Officer (CISO) duties such as counter-threat intelligence.

 Our information security program also includes a cybersecurity Incident Response Plan ("IRP") that is designed to help protect the integrity, availability and confidentiality of information,
 prevent loss of service, and comply with legal requirements. The IRP specifies the process for identifying and reporting an incident, initial investigation, risk classification, documentation and communication of incidents, responder procedures,
 incident reporting, and ongoing training. The IRP also includes processes for determining the materiality of the incident, including the assessment of relevant qualitative and quantitative factors. In the event we identify a potential
 cybersecurity, privacy or other data security issue, we have defined procedures for responding to such issues, including procedures that address when and how to engage with Company management, our board of directors, third-party advisors and
 other stakeholders.

 The Company also maintains dedicated cyber liability insurance for breach event costs including: post breach event remediation costs; cybercrime coverage (including financial fraud,
 telecommunications fraud, and phishing attacks); and coverage for system failure, bricking loss, and physical damage. The policy also provides coverage for lost revenue due to a damaged reputation from a cyber breach.

 We do not believe any risks from cybersecurity threats have materially affected or are reasonably likely to materially affect the Company or our business strategy, results of operations, or
 financial condition.

 Governance

 Our board of directors recognizes the important role of information security and mitigating cybersecurity and other data security threats. Although our full board of directors maintains ultimate
 responsibility with respect to risk management oversight, our board has delegated oversight of the Company's information security program and matters of cybersecurity to the Audit Committee of the board of directors. The Company's senior
 officers, including its Chief Information Officer, are responsible for the operation of the information security program and regularly communicate with the Audit Committee on the state of the program, risks faced by the Company and the Company's
 risk mitigation efforts related thereto.

 In addition, the Company's information technology environment is managed by an experienced team of professionals who follow an extensive set of policies and procedures related to data security.
 Our data security employees have backgrounds in cybersecurity and data protection, including prior relevant experience in the industry and industry standard certifications.

 Item 2.

 Properties

 Leased Properties. The Company
 leases space for its principal offices and for some of its insurance operations in an office building located in Atlanta, Georgia under a lease which continues until either party provides written notice of cancellation at least twelve months in
 advance of the actual termination date. The lease, which commenced on November 1, 2007, provides for rent adjustments on every fifth anniversary of the commencement date. Under the current terms of the lease, the Company occupies approximately
 49,586 square feet of office space. In December 2022, Delta Life Insurance Company, the owner of the building, transferred title to the building to 4370 Peachtree LLC. Each of Delta Life Insurance Company and 4370 Peachtree LLC is controlled by
 an affiliate of the Company.

 American Southern leases space for its office in a building located in Atlanta, Georgia. The lease term expires September 30, 2026. Under the terms of the lease, American Southern occupies
 approximately 17,014 square feet.

 The Company believes that its current properties are in good condition, and are sufficient for the operations of its business.

 Item 3.

 Legal Proceedings

 From time to time, the Company and its subsidiaries are, and expect to continue to be, involved in various claims and lawsuits arising in the ordinary course of business, both as a liability
 insurer defending third-party claims brought against insureds and as an insurer defending coverage claims brought against it, and in various regulatory proceedings in the states in which we do business. The Company accounts for such exposures
 through the establishment of loss and loss adjustment expense reserves and accrued expenses. We currently do not expect that the ultimate liability, if any, with respect to such ordinary-course claims litigation or regulatory proceedings, after
 consideration of provisions made for probable losses and costs of defense, will be material to the Company's consolidated financial condition, although the results of such matters could be material to the consolidated results of operations for
 any given period.

 Item 4.

 Mine Safety Disclosures

 Not applicable.

 Item 5.

 Market for Registrant's Common Equity, Related Shareholder Matters and Issuer
 Purchases of Equity Securities

 The Company's common stock is listed on the Nasdaq Global Market (Symbol: AAME). As of March 13, 2024, there were 1,286
 shareholders of record.

 On April 1, 2024, the Company announced that the board of directors declared an annual cash dividend of $0.02 per share of common
 stock that is payable to shareholders of record at the close of business on April 12, 2024. On August 8, 2023, the Company announced that the board of directors declared an annual cash dividend of $0.02 per share, which was paid on September 12, 2023 to shareholders of record as of August 22, 2023.

 The declaration and payment of any future dividends will be at the discretion of the Company's board of directors and will depend
 upon the financial condition, capital requirements, and earnings of the Company, as well as any restrictions contained in any agreements by which the Company is bound and other factors as the board of directors may deem relevant. The Company's
 primary recurring source of cash for the payment of dividends is dividends from its subsidiaries; although as of December 31, 2023, the Parent held unrestricted cash and investment balances of approximately $4.7 million. Under the insurance
 code of the state in which each insurance subsidiary is domiciled, dividend payments to the Parent by its insurance subsidiaries are subject to certain limitations, including prior notice to, or approval by, the state insurance commissioners if
 such dividends are in excess of specified amounts. In 2024, dividend payments to the Parent by the insurance subsidiaries in excess of $8.8 million would require prior approval.

 Issuer Purchases of Equity Securities

 On October 31, 2016, the board of directors of the Company approved a plan that allows for the repurchase of up to 750,000 shares of the Company's common stock (the "Repurchase Plan") on the open
 market or in privately negotiated transactions, as determined by an authorized officer of the Company. Any such repurchases can be made from time to time in accordance with applicable securities laws and other requirements.

 Other than pursuant to the Repurchase Plan, no purchases of common stock of the Company were made by or on behalf of the Company during the periods described below.

 The table below sets forth information regarding repurchases by the Company of shares of its common stock on a monthly basis during the three month period ended December 31, 2023.

 Period

 Total

 Number

 of Shares

 Purchased

 Average

 Price Paid

 per Share

 Total

 Number of Shares

 Purchased as Part of

 Publicly Announced

 Plans or Programs

 Maximum

 Number of Shares

 that May Yet be

 Purchased Under the

 Plans or Programs

 October 1 – October 31, 2023

 —

 $

 —

 —

 325,129

 November 1 – November 30, 2023

 —

 —

 —

 325,129

 December 1 – December 31, 2023

 —

 —

 —

 325,129

 Total

 —

 $

 —

 —

 Stock Performance Graph

 As a smaller reporting company, we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the information required by this Item.

 Item 6.

 Reserved

 Item 7.

 Management's Discussion and Analysis of Financial Condition and Results of Operations

 The following is management's discussion and analysis of the financial condition and results of operations of Atlantic American Corporation ("Atlantic American" or the "Parent") and its
 subsidiaries (collectively with the Parent, the "Company") for the years ended December 31, 2023 and 2022. This discussion should be read in conjunction with the consolidated financial statements and notes thereto included elsewhere herein.

 Atlantic American is an insurance holding company whose operations are conducted primarily through its insurance subsidiaries: American Southern Insurance Company and American Safety Insurance
 Company (together known as "American Southern") in the property and casualty insurance industry, and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (together known as
 "Bankers Fidelity") in the life and health insurance industry. Each operating company is managed separately, offers different products and is evaluated on its individual performance.

 Critical Accounting Policies

 The accounting and reporting policies of the Company are in accordance with accounting principles generally accepted in the United States of America ("GAAP") and, in management's belief, conform
 to general practices within the insurance industry. The following is an explanation of the Company's accounting policies and the resultant estimates considered most significant by management. These accounting policies inherently require
 significant judgment and assumptions and actual operating results could differ significantly from management's estimates determined using these policies. Atlantic American does not expect that changes in the estimates determined using these
 policies will have a material effect on the Company's financial condition or liquidity, although changes could have a material effect on its consolidated results of operations.

 Cash and investments comprised
 70% of the Company's total assets at December 31, 2023. Substantially all of the Company's investments are in bonds and common and preferred stocks, the values of which are subject to significant market fluctuations. The Company carries all
 fixed maturities, which includes bonds and redeemable preferred stocks, as available for sale, and equity securities, which includes common and non-redeemable preferred stocks, at their estimated fair values.

 Prior to January 1, 2023, the Company applied other than temporary impairment ("OTTI") guidance for securities in an unrealized loss position. An OTTI was recognized in earnings within realized
 investment gains (losses) when it was anticipated that the amortized cost would not be recovered. When either: (i) the Company had the intent to sell the security, or (ii) it was more likely than not that the Company would be required to sell the
 security before recovery, the reduction of amortized cost and the OTTI recognized in earnings was the entire difference between the security's amortized cost and estimated fair value. If neither of these conditions existed, the difference between
 the amortized cost of the security and the present value of projected future cash flows expected to be collected was recognized as a reduction of amortized cost and an OTTI in earnings. If the estimated fair value was less than the present value
 of projected future cash flows expected to be collected, this portion of the decline in value related to other-than-credit factors was recorded in OCI.

 On January 1, 2023, the Company adopted accounting standards update ("ASU") 2016-13, Financial Instruments-Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments ("ASU
 2016-13"), using a modified retrospective approach. Under ASU 2016-13, for securities in an unrealized loss position, a credit loss is recognized in earnings within realized investment gains (losses) when it is anticipated that the amortized cost
 will not be recovered. When either: (i) the Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the reduction of amortized cost and the loss
 recognized in earnings is the entire difference between the security's amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected
 future cash flows expected to be collected is recognized as a credit loss by establishing an ACL with a corresponding charge to earnings in realized investment gains (losses). However, the ACL is limited by the amount that the fair value is less
 than the amortized cost. This limitation is known as the "fair value floor." If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of the decline in value related to
 other-than-credit factors ("noncredit loss") is recorded in OCI.

 The Company determines the fair values of certain financial instruments based on the fair value hierarchy established in Accounting Standards Codification ("ASC") 820-10-20, Fair Value Measurements and Disclosures ("ASC 820-10-20"). The fair values of fixed maturities and equity securities are largely determined by nationally quoted market prices, when available, or independent
 broker quotations. See Note 2 and Note 3 of Notes to Consolidated Financial Statements with respect to assets and liabilities carried at fair value and information about the inputs used to value those financial instruments, by hierarchy level, in
 accordance with ASC 820-10-20.

 Future policy benefits
 comprised 34% of the Company's total liabilities at December 31, 2023. These liabilities relate primarily to life insurance products and are based upon assumed future investment yields, mortality rates, and lapse rates after giving effect to
 possible risks of adverse deviation. The assumed mortality and lapse rates are based upon the Company's experience modified as necessary to reflect anticipated trends and are generally established at contract inception. If actual results differ
 from the initial assumptions, the amount of the Company's recorded liability could require adjustment.

 Unpaid loss and loss adjustment expenses comprised 32% of the Company's total liabilities at December 31, 2023. This liability includes estimates for: (1) unpaid losses on claims reported prior to December 31, 2023, (2) future development on those reported claims, (3) unpaid
 ultimate losses on claims incurred prior to December 31, 2023 but not yet reported and (4) unpaid loss adjustment expenses for reported and unreported claims incurred prior to December 31, 2023. Quantification of loss estimates for each of
 these components involves a significant degree of judgment and estimates may vary, materially, from period to period. Estimated unpaid losses on reported claims are developed based on historical experience with similar claims by the Company.
 Development on reported claims, estimates of unpaid ultimate losses on claims incurred prior to December 31, 2023 but not yet reported, and estimates of unpaid loss adjustment expenses are developed based on the Company's historical experience,
 using actuarial methods to assist in the analysis. The Company's actuaries develop ranges of estimated development on reported and unreported claims as well as loss adjustment expenses using various methods, including the paid-loss development
 method, the reported-loss development method, the paid Bornhuetter-Ferguson method and the reported Bornhuetter-Ferguson method. Any single method used to estimate ultimate losses has inherent advantages and disadvantages due to the trends and
 changes affecting the business environment and the Company's administrative policies. Further, external factors, such as legislative changes, medical cost inflation, and others may directly or indirectly impact the relative adequacy of
 liabilities for unpaid losses and loss adjustment expenses. The Company's approach is to select an estimate of ultimate losses based on comparing results of a variety of reserving methods, as opposed to total reliance on any single method.
 Unpaid loss and loss adjustment expenses are reviewed periodically for significant lines of business, and when current results differ from the original assumptions used to develop such estimates, the amount of the Company's recorded liability
 for unpaid loss and loss adjustment expenses is adjusted. In the event the Company's actual reported losses in any period are materially in excess of the previously estimated amounts, such losses, to the extent reinsurance coverage does not
 exist, could have a material adverse effect on the Company's results of operations.

 Receivables are amounts due
 from reinsurers, insureds and agents, and any sales of investment securities not yet settled, and comprised 12% of the Company's total assets at December 31, 2023. Insured and agent balances are evaluated periodically for collectibility.
 Annually, the Company performs an analysis of the creditworthiness of the reinsurers with whom the Company contracts using various data sources. Failure of reinsurers to meet their obligations due to insolvencies, disputes or otherwise could
 result in uncollectible amounts and losses to the Company. Allowances for uncollectible amounts are established, as and when a loss has been determined probable, against the related receivable. Losses are recognized by the Company when
 determined on a specific account basis and a general provision for loss is made based on the Company's historical experience.

 Deferred acquisition costs
 comprised 12% of the Company's total assets at December 31, 2023. Deferred acquisition costs are commissions, premium taxes, and other incremental direct costs of contract acquisition that results directly from and are essential to the contract
 transaction(s) and would not have been incurred by the Company had the contract transaction(s) not occurred. The deferred amounts are recorded as an asset on the balance sheet and amortized to expense in a systematic manner. Traditional life
 insurance and long-duration health insurance deferred policy acquisition costs are amortized over the estimated premium-paying period of the related policies using assumptions consistent with those used in computing the related liability for
 policy benefit reserves. Deferred acquisition costs for property and casualty insurance and short-duration health insurance are amortized over the effective period of the related insurance policies. Deferred policy acquisition costs are
 expensed when such costs are deemed not to be recoverable from future premiums (for traditional life and long-duration health insurance) and from the related unearned premiums and investment income (for property and casualty and short-duration
 health insurance). Assessments of recoverability for property and casualty and short-duration health insurance are extremely sensitive to the estimates of a subsequent year's projected losses related to the unearned premiums. Projected loss
 estimates for a current block of business for which unearned premiums remain to be earned may vary significantly from the indicated losses incurred in any previous calendar year.

 Deferred income taxes reflect
 the effect of temporary differences between assets and liabilities that are recognized for financial reporting purposes and the amounts that are recognized for tax purposes. These deferred income taxes are measured by applying currently enacted
 tax laws and rates. Valuation allowances are recognized to reduce the deferred tax asset to the amount that is deemed more likely than not to be realized. In assessing the likelihood of realization, management considers estimates of future
 taxable income and tax planning strategies.

 Share-based transactions include

 employee and director share-based compensation awards. The Company determines a grant date fair value based on the price of our publicly-traded common stock and recognize the related compensation
 expense, adjusted for actual forfeitures, in the consolidated statement of operations on a straight-line basis over the requisite service period for the entire award. For non-employee share-based compensation awards, the Company recognizes the
 impact during the period of performance, and the fair value of the award is measured as of the date performance is complete, which is the vesting date.

 Refer to Note 1 of Notes to Consolidated Financial Statements for details regarding the Company's significant accounting policies.

 Overall Corporate Results

 2023

 2022

 Revenue

 Property and Casualty:

 $

 72,846

 $

 73,949

 Life and Health:

 114,199

 114,015

 Corporate and Other

 (252

)

 (113

)

 Total revenue

 $

 186,793

 $

 187,851

 Property and Casualty:

 $

 5,085

 $

 6,613

 Life and Health:

 4,722

 3,812

 Corporate and Other

 (10,372

)

 (8,329

)

 $

 (565

)

 $

 2,096

 $

 (171

)

 $

 1,525

 Management also considers and evaluates performance by analyzing the non-GAAP measure operating income or loss, and believes it is a useful metric for investors, potential investors, securities
 analysts and others because it isolates the "core" operating results of the Company before considering certain items that are either beyond the control of management (such as income tax expense, which is subject to timing, regulatory and rate
 changes depending on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company's operational results (such as any realized or unrealized investment gains or losses, which are not a part of the
 Company's primary operations and are, to a limited extent, subject to discretion in terms of timing of realization).

 A reconciliation of net income, the most directly comparable GAAP measure, to operating income is as follows:

 2023

 2022

 Reconciliation of Non-GAAP Financial Measure

 $

 (171

)

 $

 1,525

 Income tax expense (benefit)

 (394

)

 (70

)

 (30

)

 2,177

 7,562

 Non-GAAP operating income

 $

 1,542

 $

 9,628

 On a consolidated basis, the Company had net loss of $0.2 million, or $0.03 per diluted share, in 2023, compared to net income of $1.5 million, or $0.06 per diluted share, in 2022. The decrease
 in net income was primarily due to a decrease in earned premiums, as well as an increase in losses and expenses as a percentage of premiums. Also contributing to the decrease in net income is an increase in debt service costs due to rising
 interest rates. Partially offsetting this decrease was a decline in unrealized losses on equity securities.

 Total revenue was $186.8 million in 2023 as compared to $187.9 million in 2022. Premium revenue decreased to $178.8 million in 2023 from $185.4 million in 2022. The decrease in premium revenue
 was primarily attributable to a decrease in Medicare supplement insurance premiums within the life and health operations. Also contributing to the decrease in premium revenue was a decrease in earned premiums in the automobile physical damage
 line of business due to a reduction in the number of programs. Partially offsetting the decrease in premium revenue was an increase in earned premiums in the automobile liability line of business due mainly to rate increases and a retrospective
 premium adjustment in a governmental program.

 Operating income was $1.5 million in 2023 as compared to $9.6 million in 2022. The decrease in operating income was primarily due to a decline in premium revenue and an increase in losses and
 expenses as a percentage of premiums, as discussed above. Partially offsetting the decline in operating income was more favorable loss experience in the life and health operations, resulting from improved rate adequacy and a decrease in the
 number of incurred claims within the Medicare supplement line of business.

 A more detailed analysis of the operating companies and other corporate activities follows.

 UNDERWRITING RESULTS

 The following table summarizes, for the periods indicated, American Southern's premiums, losses, expenses and underwriting ratios:

 2023

 2022

 Gross written premiums

 $

 77,567

 $

 79,218

 Ceded premiums

 (5,902

)

 (6,547

)

 Net written premiums

 $

 $

 Net earned premiums

 $

 $

 51,015

 47,175

 Commissions and underwriting expenses

 16,746

 20,161

 Underwriting income

 $

 $

 2,940

 Loss ratio

 74.5

 %

 67.1

 %

 Expense ratio

 24.5

 28.7

 Combined ratio

 99.0

 %

 95.8

 %

 Gross written premiums at American Southern decreased $1.7 million, or 2.1%, during 2023 as compared to 2022. The decrease in gross written premiums was primarily attributable to the decrease in
 premiums written in the automobile physical damage line of business due to a reduction in the number of agencies. Partially offsetting the decrease in gross written premiums was an increase in premiums written in the automobile liability line of
 business resulting from new business, rate increases, and retrospective premium adjustments.

 Ceded premiums decreased $0.6 million, or 9.9%, during 2023 as compared to 2022. American Southern's ceded premiums are typically determined as a percentage of earned premiums and generally
 increase or decrease as earned premiums increase or decrease. The decrease in ceded premiums was primarily attributable to the decrease in earned premiums in the automobile physical damage line of business, as well as decreased ceding rates due
 to increased retention.

 The following table summarizes, for the periods indicated, American Southern's net earned premiums by line of business:

 2023

 2022

 Automobile liability

 $

 38,821

 $

 33,981

 Automobile physical damage

 15,046

 21,069

 General liability

 5,758

 5,871

 6,303

 6,039

 Other lines

 2,515

 3,316

 Total

 $

 $

 Net earned premiums decreased $1.8 million, or 2.6%, during 2023 as compared to 2022. The decrease in net earned premiums was primarily attributable to a decrease in earned premiums in the
 automobile physical damage line of business due to a reduction in the number of agencies as previously mentioned. Also contributing to the decrease was a decline in earned premiums in the inland marine line of business resulting from reduced
 cargo production. Partially offsetting the decrease in net earned premiums was an increase in earned premiums in the automobile liability line of business due mainly to rate increases and a retrospective premium adjustment in a governmental
 program. Premiums are earned ratably over their respective policy terms and therefore premiums earned in the current year are related to policies written during both the current year and immediately preceding year.

 The performance of a property and casualty insurance company is often measured by its combined ratio. The combined ratio represents the percentage of
 losses, loss adjustment expenses and other expenses that are incurred for each dollar of premium earned by the company. A combined ratio of under 100% represents an underwriting profit while a combined ratio of over 100% indicates an underwriting
 loss. The combined ratio is divided into two components, the loss ratio (the ratio of losses and loss adjustment expenses incurred to premiums earned) and the expense ratio (the ratio of expenses incurred to premiums earned).

 Insurance benefits incurred at American Southern increased $3.8 million, or 8.1%, during 2023 as compared to 2022. As a percentage of premiums, insurance benefits and losses incurred were 74.5%
 in 2023 as compared to 67.1% in 2022. The increase in the loss ratio was mainly due to overall inflation on claims and increased severity of losses reported from certain governmental programs within the automobile liability line of business. Also
 contributing to the increase in the loss ratio were increased losses in the general liability line of business from artisan contractor business. Partially offsetting the increase in the loss ratio was a decrease in losses related to the
 automobile physical damage line of business due to a decrease in exposure.

 Commissions and underwriting expenses decreased $3.4 million, or 16.9%, during 2023 as compared to 2022. As a percentage of premiums, these expenses were 24.5% in 2023 as compared to 28.7% in
 2022. The decrease in the expense ratio was primarily due to the decrease in fixed and variable commissions. Fixed commissions decreased as a result of the decline in written premiums during 2023. Also contributing to the decrease in expense
 ratio was American Southern's use of a variable commission structure with certain agents, which compensates the participating agents in relation to the loss ratios of the business they write. During periods in which the loss ratio decreases,
 commissions and underwriting expenses will generally increase, and conversely, during periods in which the loss ratio increases, commissions and underwriting expenses will generally decrease. In 2023, variable commissions at American Southern
 decreased $1.4 million as compared to 2022 due to an increase in loss ratios from certain accounts subject to variable commissions.

 The following summarizes, for the periods indicated, Bankers Fidelity's premiums, losses and expenses:

 2023

 2022

 Medicare supplement

 $

 133,343

 $

 148,747

 Other health products

 14,373

 12,389

 Life insurance

 18,659

 15,867

 Gross earned premiums

 166,375

 177,003

 Ceded premiums

 (55,993

)

 (61,839

)

 Net earned premiums

 71,485

 76,281

 Commissions and underwriting expenses

 37,992

 33,922

 Total expenses

 109,477

 110,203

 Underwriting income

 $

 $

 4,961

 Loss ratio

 64.8

 %

 66.2

 %

 Expense ratio

 34.4

 29.5

 Combined ratio

 99.2

 %

 95.7

 %

 Net earned premium revenue at Bankers Fidelity decreased $4.8 million, or 4.2%, during 2023 as compared to 2022. Gross earned premiums from the Medicare supplement line of business decreased
 $15.4 million, or 10.4 %, in 2023 as compared to 2022, due primarily to non-renewals exceeding the level of new business writings as the existing block of business has incurred rate increases. Other health product premiums increased $2.0 million,
 or 16.0%, during 2023 as compared to 2022, primarily as a result of new sales of the company's group health and individual cancer products. Gross earned premiums from the life insurance line of business increased $2.8 million, or 17.6%, in 2023
 from 2022 due to an increase in the group life product premiums. Partially offsetting this increase was a decrease in individual life products premium, resulting from the redemption and settlement of existing individual life policy obligations
 exceeding the level of new individual life sales. Premiums ceded decreased $5.8 million, or 9.5%, in 2023 from 2022. The decrease in ceded premiums was due to a decrease in Medicare supplement premiums subject to reinsurance.

 Insurance benefits and losses incurred decreased $4.8 million, or 6.3%, during 2023 as compared to 2022. As a percentage of premiums, benefits and losses were 64.8% in 2023 as compared to 66.2%
 in 2022. The decrease in the loss ratio was primarily due to improved rate adequacy and a decrease in the number of incurred claims within the Medicare supplement line of business. Also contributing to the decrease in loss ratio was an
 improvement in the other health lines profitability. These decreases were offset by higher incurred claims on our life lines of business.

 Commissions and underwriting expenses increased $4.1 million, or 12.0%, during 2023 as compared to 2022. As a percentage of earned premiums, these expenses were 34.4% in 2023 as compared to 29.5%
 in 2022. The increase in the expense ratio was primarily due to an increase in administrative costs related to growth in the group and individual health lines of business, coupled with increased Medicare supplement servicing costs.

 Net Investment Income and Realized Gains

 Investment income increased $0.1 million, or 1.3%, in 2023 as compared to 2022. The increase in investment income was primarily attributable to an increase in investment income related to fixed
 maturities and equity securities. Partially offsetting this increase was a decrease in the equity in earnings from investments in the Company's limited partnerships and limited liability companies of $0.6 million.

 The Company had net realized investment gains of $0.1 million in 2023 as compared to net realized investment gains of $0.03 million in 2022. The net realized investment gains in 2023 and 2022
 were primarily attributable to gains from the sale of fixed maturities. Management continually evaluates the Company's investment portfolio and, as may be determined to be appropriate, makes adjustments for impairments and/or will divest
 investments. See Note 2 of Notes to Consolidated Financial Statements.

 Unrealized Losses on Equity Securities, Net

 Investments in equity securities are measured at fair value at the end of the reporting period, with any changes in fair value reported in net income during the period. The Company recognized net
 unrealized losses on equity securities of $2.2 million and $7.6 million during the years ended December 2023 and 2022, respectively. Changes in unrealized gains on equity securities for the applicable periods are primarily the result of
 fluctuations in the market value of certain of the Company's equity securities.

 Interest Expense

 Interest expense increased $1.3 million, or 67.5%, in 2023 as compared to 2022. Changes in interest expense were primarily due to changes in the Term Secured Overnight Financing Rate ("SOFR")
 published by CME Group Benchmark Administration Limited ("CME"), as the interest rates on the Company's outstanding junior subordinated deferrable interest debentures ("Junior Subordinated Debentures") and the revolving credit facility are
 directly related to SOFR. As expected, discontinuation of London Interbank Offered Rate ("LIBOR") occurred on June 30, 2023 and affected the rates used in the Company's credit arrangements after that date. The U.S. Congress enacted the Adjustable
 Interest Rate LIBOR Act (the "LIBOR Act") to address LIBOR's cessation and the Board of Governors of the Federal Reserve System issued regulations, 12 C.F.R. Part 253, "Regulations Implementing the Adjustable Interest Rate LIBOR Act (Regulation
 ZZ)," which relate to the LIBOR transition.

 Income Taxes

 The primary difference between the effective tax rate and the federal statutory income tax rate for 2023 resulted from the adjustment for prior years' estimates to actual of $0.3 million in the
 year ended December 31, 2023, which included the return to provision adjustment that is generally updated at the completion of the third quarter of each fiscal year and an adjustment for partnership valuation. Also contributing to the differences
 between the effective tax rate and the federal statutory income tax rate was a permanent difference related to meals and entertainment.

 The primary differences between the effective tax rate and the federal statutory income tax rate for 2022 resulted from a permanent difference related to penalties and fines incurred of $0.1
 million. Also contributing to differences between the effective tax rate and the federal statutory income tax rate were the adjustment for prior years' estimates to actual that are generally updated at the completion of the third quarter of each
 fiscal year and were $0.1 million in the year ended December 31, 2022. Other contributing factors to the differences between the effective tax rate and the federal statutory income tax rate were permanent
 differences related to meals and entertainment and the dividends-received deduction ("DRD"). The current estimated DRD is adjusted as underlying factors change and can vary from estimates based on, but not limited to, actual distributions from
 investments as well as the amount of the Company's taxable income.

 Liquidity and Capital Resources

 The primary cash needs of the Company are for the payment of claims and operating expenses, maintaining adequate statutory capital and surplus levels, and meeting debt service requirements.
 Current and expected patterns of claim frequency and severity may change from period to period, but generally are expected to continue within historical ranges. The Company's primary sources of cash are written premiums, investment income and
 proceeds from the sale and maturity of its invested assets, as well as borrowings from time to time under our revolving credit facility. The Company believes that, within each operating company, total invested assets will be sufficient to
 satisfy all policy liabilities and that cash inflows from investment earnings, future premium receipts and reinsurance collections will be adequate to fund the payment of claims and operating expenses as needed.

 Cash flows at the Parent are derived from dividends, management fees, and tax-sharing payments, as described below, from the subsidiaries. The principal cash needs of the Parent are for the
 payment of operating expenses, the acquisition of capital assets and debt service requirements, as well as the repurchase of shares and payments of any dividends as may be authorized and approved by the Company's board of directors from time to
 time. At December 31, 2023, the Parent had approximately $4.7 million of unrestricted cash and investments.

 Dividend payments to a parent corporation by its wholly owned insurance subsidiaries are subject to annual limitations and are restricted to 10% of statutory surplus or statutory earnings before
 recognizing realized investment gains of the individual insurance subsidiaries. At December 31, 2023, the Parent's insurance subsidiaries had an aggregate statutory surplus of $90.1 million. Dividends were paid to Atlantic American by its
 subsidiaries totaling $8.4 million and $7.2 million in 2023 and 2022, respectively.

 The Parent provides certain administrative, purchasing and other services to each of its subsidiaries. The amount charged to and paid by the subsidiaries for these services was $8.7 million and
 $7.6 million in 2023 and 2022, respectively. In addition, the Parent has a formal tax-sharing agreement with each of its insurance subsidiaries. A net total of $4.0 million and $3.9 million were paid to the Parent under the tax sharing agreement
 in 2023 and 2022, respectively.

 The Company has two statutory trusts which exist for the exclusive purpose of issuing trust preferred securities representing undivided beneficial interests in the assets of the trusts and
 investing the gross proceeds of the trust preferred securities in Junior Subordinated Debentures. The outstanding $18.0 million and $15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are
 callable quarterly, in whole or in part, only at the option of the Company, and have an interest rate of 3-month CME Term SOFR plus applicable tenor spread of 0.26161 percent plus an applicable margin. The margin ranges from 4.00% to 4.10%. At
 December 31, 2023, the effective interest rate was 9.69%. The obligations of the Company with respect to the issuances of the trust preferred securities represent a full and unconditional guarantee by the Parent of each trust's obligations with
 respect to the trust preferred securities. Subject to certain exceptions and limitations, the Company may elect from time to time to defer Junior Subordinated Debenture interest payments, which would result in a deferral of distribution payments
 on the related trust preferred securities. The Company has not made such an election.

 The Company intends to pay its obligations under the Junior Subordinated Debentures using existing cash balances, dividend and tax-sharing payments from the operating subsidiaries, or from
 existing or potential future financing arrangements.

 At December 31, 2023, the Company had 55,000 shares of Series D preferred stock ("Series D Preferred Stock") outstanding. All of the shares of Series D Preferred Stock are held by an affiliate of
 the Company's controlling shareholder. The outstanding shares of Series D Preferred Stock have a redemption value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company's common stock at
 the option of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company's common stock,
 subject to certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the
 Company's option. The Series D Preferred Stock is not currently convertible. The Company had accrued, but unpaid, dividends on the Series D Preferred Stock of $17.7 thousand at December 31, 2023 and 2022. During each of 2023 and 2022, the Company
 paid Series D Preferred Stock dividends of $0.4 million.

 Bankers Fidelity Life Insurance Company (''BFLIC") is a member of the Federal Home Loan Bank of Atlanta ("FHLB"), for the primary purpose of enhancing financial flexibility. As a member, BFLIC
 can obtain access to low-cost funding and also receive dividends on FHLB stock. The membership arrangement provides for credit availability of five percent of statutory admitted assets, or approximately $8.0 million, as of December 31, 2023.
 Additional FHLB stock purchases may be required based upon the amount of funds borrowed from the FHLB. As of December 31, 2023, BFLIC has pledged bonds having an amortized cost of $9.6 million to the FHLB. BFLIC may be required to post
 additional acceptable forms of collateral for any borrowings that it makes in the future from the FHLB. As of December 31, 2023, BFLIC does not have any outstanding borrowings from the FHLB.

 On May 12, 2021, the Company entered into a Revolving Credit Agreement (the "Credit Agreement") with Truist Bank as the lender (the "Lender"). The Credit Agreement provides for an unsecured $10.0
 million revolving credit facility that matures on April 12, 2024. Under the Credit Agreement, the Company paid interest on the unpaid principal balance of outstanding revolving loans at 1-month SOFR plus a spread adjustment of 0.11448% plus
 2.00%, subject to a SOFR floor rate of 1.00%.

 The Credit Agreement requires the Company to comply with certain covenants, including a debt to capital ratio that restricts the Company from incurring consolidated indebtedness that exceeds 35%
 of the Company's consolidated capitalization at any time. The Credit Agreement also contains customary representations and warranties and events of default. Events of default include, among others, (a) the failure by the Company to pay any
 amounts owed under the Credit Agreement when due, (b) the failure to perform and not timely remedy certain covenants, (c) a change in control of the Company and (d) the occurrence of bankruptcy or insolvency events. Upon an event of default, the
 Lender may, among other things, declare all obligations under the Credit Agreement immediately due and payable and terminate the revolving commitments. As of December 31, 2023, the Company had outstanding borrowings of $3.0 million under the
 Credit Agreement.

 Cash and cash equivalents decreased from $28.9 million at December 31, 2022 to $28.3 million at December 31, 2023. The decrease in cash and cash equivalents during 2023 was primarily attributable
 to a decrease in net cash used in investing activities of $3.4 million primarily as a result of investment purchases exceeding investment sales and maturity of securities. Partially offsetting the decrease in cash and cash equivalents was an
 increase in net cash provided by operating activities of $2.6 million.

 The Company believes that existing cash balances as well as the dividends, fees, and tax-sharing payments it expects to receive from its subsidiaries and, if needed, additional borrowings from
 financial institutions, will enable the Company to meet its liquidity requirements for the next 12 months and thereafter for the foreseeable future. Management is not aware of any current recommendations by regulatory authorities, which, if
 implemented, would have a material adverse effect on the Company's liquidity, capital resources or operations.

 New Accounting Pronouncements

 See "Recently Issued Accounting Standards" in Note 1 of Notes to Consolidated Financial Statements.

 Impact of Inflation

 Insurance premiums are established before the amount of losses and loss adjustment expenses, or the extent to which inflation may affect such losses and expenses, are known. Consequently, in
 establishing its premiums, the Company attempts to anticipate the potential impact of inflation. If, for competitive reasons, premiums cannot be increased to anticipate inflation, this cost would be absorbed by the Company. Inflation also affects
 the rate of investment return on the Company's investment portfolio with a corresponding effect on investment income. During 2023, inflation was a factor in increased loss experience within the Company's automobile liability line of business.

 Item 7A.

 Quantitative and Qualitative Disclosures About Market Risk

 As a smaller reporting company, we have elected to comply with certain scaled disclosure reporting obligations, and therefore are not providing the information required by this Item.

 Item 8.

 Financial Statements and Supplementary Data

 INDEX TO FINANCIAL STATEMENTS

 Page

 Report of Independent Registered Public Accounting Firm ( FORVIS, LLP), Atlanta, Georgia, PCAOB Firm ID No. 686)

 Consolidated Balance Sheets as of December 31, 2023 and 2022

 Consolidated Statements of Operations for the years ended December 31, 2023 and 2022

 Consolidated Statements of Comprehensive Income (Loss) for the years ended December 31, 2023 and 2022

 Consolidated Statements of Shareholders' Equity for the years ended December 31, 2023 and 2022

 Consolidated Statements of Cash Flows for the years ended December 31, 2023 and 2022

 Notes to Consolidated Financial Statements

 REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 Board of Directors and Shareholders

 Atlantic American Corporation

 Atlanta, GA

 Opinion on the Consolidated Financial Statements

 We have audited the accompanying consolidated balance sheets of Atlantic American Corporation and subsidiaries (the "Company") as of
 December 31, 2023, and 2022, and the related consolidated statements of operations, comprehensive loss, shareholders' equity and cash flows for each of the years in the two-year period ended December 31, 2023, and the related notes and schedules
 (collectively, referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2023, and 2022, and the results of its
 operations and its cash flows for each of the years in the two-year period ended December 31, 2023, in conformity with accounting principles generally accepted in the United States of America (US GAAP).

 Basis for Opinion

 These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements
 based on our audits.

 We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) ("PCAOB") and are required to be independent with
 respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance
 about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of internal control over financial reporting. As part of our
 audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company's internal control over financial reporting. Accordingly, we
 express no such opinion.

 Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and
 performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used
 and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 Critical Audit Matters

 The critical audit matters communicated below are matters arising from the current period audit of the financial statements that were communicated or required to be
 communicated to the audit committee and that: (1) relate to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit
 matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or
 disclosures to which they relate.

 Valuation of Insurance Reserves for Losses and Claims (Claim Reserves)

 As reflected on the consolidated balance sheet and discussed in Note 6 to the financial statements, the Company's insurance reserves for losses and claims (claim
 reserves), were $87.5 million as of December 31, 2023. The Company's claim reserves relate primarily to its property casualty lines of business and Medicare supplement business. The process of establishing claim reserves requires the use of
 estimates and judgments based on circumstances underlying the insured loss at the date of accrual. Management's judgments include claims adjusters' evaluations for unpaid claims reported prior to the close of the accounting period, estimates of
 incurred but not reported (IBNR) claims based on past experience and estimates of loss adjustment expenses.

 The principal considerations for our determination that the valuation of claim reserves is a critical audit matter are the high degree of judgment and subjectivity
 in auditing the actuarial methods and assumptions used in the valuation process, including assumptions around expected loss ratios and reported and paid loss emergence patterns.

 Addressing the matter involved performing the following audit procedures, among others:

 •

 Involving our actuarial specialists to assist in our procedures in:

 o

 Evaluating the appropriateness of management's actuarial reserving methodologies and assumptions;

 o

 Evaluating management's hindsight analyses;

 o

 Comparing management's carried reserve to the range calculated by management's specialist for property casualty claim reserves;

 •

 Testing the completeness and accuracy of data provided by management that served as the basis for the actuarial analyses on a sample basis; and

 •

 Evaluating movement of the Company's recorded property casualty claim reserves within the Company's estimated reserve range year over year.

 Valuation of Insurance Reserves for Future Policy Benefits (Policy Reserves)

 As reflected on the consolidated balance sheet and discussed in Note 6 to the financial statements, the Company's insurance reserves for future policy
 benefits (policy reserves) were $92.5 million as of December 31, 2023. Policy reserves are related to life and health insurance policies and are based upon significant assumptions including future investment yields, mortality rates, withdrawal
 rates and expenses after giving effect to possible risks of unexpected claim experience. These assumptions are based on historical experience modified as necessary to reflect anticipated trends and are generally established at contract inception.

 The principal considerations for our determination that the valuation of policy reserves is a critical audit matter are the high degree of judgment
 required to assess certain assumptions that impact policy reserves and the complexity of the actuarial calculations.

 Addressing the matter involved performing the following audit procedures, among others:

 •

 Involving our actuarial specialists to assist in our procedures in:

 o

 Evaluating whether the methodology applied by management is consistent in the aggregate with the methodology compliant with US GAAP;

 o

 Assessing the significant assumptions used by management for new insurance contracts issued during the current year by comparing the significant assumptions noted
 above to historical experience, observable market data or management's estimates of prospective changes to these assumptions;

 o

 Reviewing benefit reserve replication workbooks prepared by management for a sample of contracts; and

 o

 Evaluating management's loss recognition testing of aggregate reserve sufficiency.

 •

 Testing the completeness and accuracy of data used by management in developing assumptions on a sample basis.

 We have served as the Company's auditor since 2018.

 /s/ FORVIS, LLP

 Atlanta, GA

 CONSOLIDATED

 BALANCE SHEETS

 December 31,

 2023

 2022

 (In thousands,

 except share and per

 share data)

 ASSETS

 Cash and cash equivalents

 $

 28,301

 $

 Investments:

 Fixed maturities, available-for-sale, at fair value (amortized cost: $ 238,626 and
 $ 236,766; no allowance for credit losses)

 Equity securities, at fair value (cost: $ 4,936 and $ 4,907)

 9,413

 Other invested assets (cost: $ 6,982 and $ 5,628)

 6,381

 5,386

 Policy loans

 1,778

 1,759

 Real estate

 Investment in unconsolidated trusts

 1,238

 1,238

 Total investments

 237,067

 228,712

 Receivables:

 Reinsurance (net of allowance for uncollectible reinsurance of $ 61 and $ 0)

 21,103

 25,913

 Insurance premiums and other (net of allowance for expected credit losses $ 217 and
 net of allowance for doubtful accounts $ 177)

 23,690

 15,386

 Deferred income taxes, net

 15,682

 14,163

 Deferred acquisition costs

 43,850

 42,281

 Other assets

 9,028

 9,202

 Intangibles

 2,544

 2,544

 Total assets

 $

 381,265

 $

 367,064

 LIABILITIES AND SHAREHOLDERS' EQUITY

 Insurance reserves and policyholder funds

 Future policy benefits

 $

 92,495

 $

 85,564

 Unearned premiums

 31,317

 28,348

 Losses and claims

 87,478

 87,484

 Other policy liabilities

 1,132

 1,255

 Total insurance reserves and policyholder funds

 212,422

 202,651

 Accounts payable and accrued expenses

 24,811

 26,473

 Revolving credit facility

 3,019

 2,009

 Junior subordinated debenture obligations, net

 Total liabilities

 273,990

 264,871

 Commitments and contingencies (Note 17)

 Shareholders' equity:

 Preferred stock, $ 1 par, 4,000,000 shares authorized; Series D preferred, 55,000
 shares issued and outstanding; $ 5,500 redemption value

 Common stock, $ 1 par, 50,000,000 shares authorized; 22,400,894 shares
 issued; 20,402,288 and 20,407,229
 shares outstanding as of 2023 and 2022, respectively

 Additional paid-in capital

 Retained earnings

 50,929

 51,982

 Accumulated other comprehensive loss

 ( 16,121

)

 ( 22,149

)

 Unearned stock grant compensation

 ( 13

)

 ( 132

)

 Treasury stock, at cost, 1,998,606 and 1,993,665 shares as of 2023 and 2022, respectively

 ( 7,401

)

 ( 7,389

)

 Total shareholders' equity

 107,275

 102,193

 Total liabilities and shareholders' equity

 $

 381,265

 $

 367,064

 CONSOLIDATED STATEMENTS OF
 OPERATIONS

 2023

 2022

 (In thousands,

 except per share data)

 Revenue:

 Insurance premiums, net

 $

 $

 Net investment income

 9,932

 ( 2,177

)

 ( 7,562

)

 Other income

 Total revenue

 186,793

 187,851

 Benefits and expenses:

 Commissions and underwriting expenses

 46,124

 46,713

 Interest expense

 3,269

 1,952

 Other expense

 15,465

 13,634

 Total benefits and expenses

 187,358

 185,755

 ( 565

)

 2,096

 Income tax expense (benefit)

 ( 394

)

 ( 171

)

 1,525

 Preferred stock dividends

 ( 399

)

 ( 399

)

 Net income (loss) applicable to common shareholders

 $

 ( 570

)

 $

 1,126

 Earnings (loss) per common share (basic and diluted)

 ( 0.03

)

 0.06

 CONSOLIDATED STATEMENTS OF

 COMPREHENSIVE INCOME (LOSS)

 2023

 2022

 $

 ( 171

)

 $

 1,525

 Other comprehensive gain (loss):

 Available-for-sale fixed maturity securities:

 Gross unrealized holding gain (loss) arising in the period

 7,700

 ( 50,377

)

 Related income tax effect

 ( 1,617

)

 10,579

 Subtotal

 6,083

 ( 39,798

)

 Less: reclassification adjustment for net realized gains included in net income

 ( 70

)

 ( 49

)

 Related income tax effect

 Subtotal

 ( 55

)

 ( 39

)

 Total other comprehensive income (loss), net of tax

 6,028

 ( 39,837

)

 Total comprehensive income (loss)

 $

 5,857

 $

 ( 38,312

)

 CONSOLIDATED STATEMENTS OF

 SHAREHOLDERS' EQUITY

 (In thousands, except share and per share data)

 2023

 2022

 Preferred stock:

 $

 $

 Common stock:

 Additional paid-in capital:

 57,441

 Restricted stock grants, net of forfeitures

 —

 ( 16

)

 Retained earnings:

 51,982

 51,264

 Cumulative effect of adoption of updated accounting guidance for credit losses at January 1, 2023

 ( 75

)

 —

 ( 171

)

 1,525

 Dividends on common stock

 ( 408

)

 ( 408

)

 Dividends accrued on preferred stock

 ( 399

)

 ( 399

)

 50,929

 51,982

 Accumulated other comprehensive income (loss):

 ( 22,149

)

 17,688

 Other comprehensive income (loss), net of tax

 6,028

 ( 39,837

)

 ( 16,121

)

 ( 22,149

)

 Unearned stock grant compensation:

 ( 132

)

 ( 73

)

 Restricted stock grants, net of forfeitures

 —

 ( 193

)

 Amortization of unearned compensation

 ( 13

)

 ( 132

)

 Treasury stock:

 ( 7,389

)

 ( 7,490

)

 Restricted stock grants, net of forfeitures

 —

 Net shares acquired related to employee share-based compensation plans

 ( 12

)

 ( 108

)

 ( 7,401

)

 ( 7,389

)

 Total shareholders' equity

 $

 107,275

 $

 102,193

 Dividends declared on common stock per share

 $

 0.02

 $

 0.02

 Common shares outstanding:

 20,407,229

 20,378,576

 Net shares acquired under employee share-based compensation plans

 ( 4,941

)

 ( 36,347

)

 Restricted stock grants, net of forfeitures

 —

 65,000

 20,402,288

 20,407,229

 CONSOLIDATED STATEMENTS OF

 CASH FLOWS

 2023

 2022

 Cash flows from operating activities:

 Net Income (loss)

 $

 ( 171

)

 $

 1,525

 Adjustments to reconcile net income to net cash provided by operating activities:

 Amortization of deferred acquisition costs

 16,440

 19,445

 Acquisition costs deferred

 ( 18,009

)

 ( 23,028

)

 ( 70

)

 ( 30

)

 2,177

 7,562

 Losses (earnings) from equity method investees

 ( 241

)

 Compensation expense related to share awards

 Provision for credit losses

 —

 Depreciation and amortization

 Deferred income tax benefit

 ( 3,121

)

 ( 1,819

)

 (Increase) decrease in receivables, net

 ( 3,520

)

 1,076

 Increase in insurance reserves and policyholder funds

 9,771

 (Decrease) increase in accounts payable and accrued expenses

 ( 1,662

)

 1,008

 Other, net

 ( 370

)

 ( 923

)

 Net cash provided by operating activities

 2,622

 6,453

 Cash flows from investing activities:

 Proceeds from investments sold

 5,044

 3,902

 Proceeds from investments matured, called or redeemed

 9,744

 9,806

 Investments purchased

 ( 18,073

)

 ( 17,010

)

 Additions to property and equipment

 ( 80

)

 ( 126

)

 Net cash used in investing activities

 ( 3,365

)

 ( 3,428

)

 Cash flows from financing activities:

 Payment of dividends on Series D preferred stock

 ( 399

)

 ( 399

)

 Payment of dividends on common stock

 ( 408

)

 ( 408

)

 Treasury stock acquired — net employee share-based compensation

 ( 12

)

 ( 108

)

 Proceeds from revolving credit facility, net

 1,000

 2,000

 Net cash provided by financing activities

 1,085

 Net (decrease) increase in cash

 ( 562

)

 4,110

 Cash and cash equivalents at beginning of year

 24,753

 Cash and cash equivalents at end of year

 $

 28,301

 $

 Supplemental cash flow information:

 Cash paid for interest

 $

 3,227

 $

 1,794

 Cash paid for income taxes

 $

 2,582

 $

 2,764

 NOTES TO CONSOLIDATED FINANCIAL
 STATEMENTS

 Note 1.

 Summary of Significant Accounting Policies

 Principles of Consolidation

 The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United
 States of America ("GAAP") which, for insurance companies, differ in some respects from the statutory accounting practices prescribed or permitted by regulatory authorities. These financial statements include the accounts of Atlantic American
 Corporation ("Atlantic American" or the "Parent") and its subsidiaries (collectively with the Parent, the "Company"). All significant intercompany accounts and transactions have been eliminated in consolidation. Operating results achieved in any
 historical period are not necessarily indicative of results to be expected in any future period.

 At December 31, 2023, the Parent owned five
 insurance subsidiaries, Bankers Fidelity Life Insurance Company and its wholly-owned subsidiaries, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (together known as "Bankers Fidelity"), and American Southern
 Insurance Company and its wholly-owned subsidiary, American Safety Insurance Company. American Southern Insurance Company also wholly-owned three
 non-insurance subsidiaries, Premier Adjusting and Claim Services, Inc., Automobile Safety Management, Inc. and Automated Systems of Georgia, Inc. (together with American Southern Insurance Company and American Safety Insurance Company known as
 "American Southern"). In addition, the Parent owned one non-insurance subsidiary, xCalibre Risk Services, Inc. The Parent has issued a
 guarantee of all liabilities of Bankers Fidelity.

 Premium Revenue and Cost Recognition

 Life insurance premiums are recognized as revenue when due; accident and health insurance premiums are recognized as revenue over the premium paying
 period and property and casualty insurance premiums are recognized as revenue over the period of the contract in proportion to the amount of insurance protection provided. Losses, benefits and expenses are accrued as incurred and are associated
 with premiums as they are earned so as to result in recognition of profits over the lives of the contracts. For traditional life insurance and long-duration health insurance, this association is accomplished by the provision of a future policy
 benefits reserve and the deferral and subsequent amortization of the costs of acquiring business, which are referred to as "deferred policy acquisition costs" (principally commissions, premium taxes, and other incremental direct costs of issuing
 policies). Deferred policy acquisition costs ("DAC") are amortized over the estimated premium-paying period of the related policies using assumptions consistent with those used in computing the future policy benefits reserve. The Company provides
 for insurance benefits and losses on accident, health, and property-casualty claims based upon estimates of projected ultimate losses. DAC for property and casualty insurance and short-duration health insurance is amortized over the effective
 period of the related insurance policies. Contingent commissions, if contractually applicable, are ultimately payable to agents based on the underlying profitability of a particular insurance contract or a group of insurance contracts, and are
 periodically evaluated and accrued as earned. In periods in which revisions are made to the estimated loss reserves related to the particular insurance contract or group of insurance contracts subject to such commissions, corresponding adjustments
 are also made to the related accruals. DAC is expensed when such costs are deemed not to be recoverable from future premiums (for traditional life and long-duration health insurance) and from the related unearned premiums and investment income (for
 property and casualty and short-duration health insurance).

 Insurance Premiums and Other Receivables

 Receivables amounts due from reinsurers, insureds and agents are evaluated
 periodically for collectibility. Allowances for expected credit losses are established, as and when a loss has been determined probable, against the related receivable. An allowance for expected credit loss is recognized by the Company when
 determined on a specific account basis and a general provision for loss is made based on the Company's historical and expected experience.

 Intangibles

 Intangibles consist of goodwill and other indefinite-lived intangible assets. Goodwill represents the excess of cost over the fair value of net
 assets acquired and is not amortized. Other indefinite-lived intangibles represent the value of licenses and are not amortized. The Company periodically reviews its goodwill and other indefinite-lived intangibles to determine if any adverse
 conditions exist that could indicate impairment. Conditions that could trigger impairment include, but are not limited to, a significant change in business climate that could affect the value of the related asset, an adverse action, or an
 assessment by a regulator. No impairment of the Company's recorded intangibles was identified during any of the periods presented.

 The Company's investments in fixed maturities, which include bonds and redeemable preferred stocks, are classified as "available-for-sale" and,
 accordingly, are carried at fair value with the after-tax difference from amortized cost, less allowance for credit losses ("ACL"), as adjusted if applicable, reflected in shareholders' equity as a component of accumulated other comprehensive
 income or loss. The Company's equity securities, which include common and non-redeemable preferred stocks, are carried at fair value with changes in fair value reported in net income. The fair values of fixed maturities and equity securities are
 largely determined from publicly quoted market prices, when available, or independent broker quotations. Values that are not determined using quoted market prices inherently involve a greater degree of judgment and uncertainty and therefore
 ultimately greater price volatility than the value of securities with publicly quoted market prices.

 Prior

 to January 1, 2023, the Company applied other than temporary impairment ("OTTI") guidance for securities in an unrealized loss position. An OTTI was recognized in earnings within realized investment gains (losses) when it was anticipated that
 the amortized cost would not be recovered. When either: (i) the Company had the intent to sell the security, or (ii) it was more likely than not that the Company would be required to sell the security before recovery, the reduction of amortized
 cost and the OTTI recognized in earnings was the entire difference between the security's amortized cost and estimated fair value. If neither of these conditions existed, the difference between the amortized cost of the security and the present
 value of projected future cash flows expected to be collected was recognized as a reduction of amortized cost and an OTTI in earnings. If the estimated fair value was less than the present value of projected future cash flows expected to be
 collected, this portion of the decline in value related to other-than-credit factors was recorded in OCI.

 On

 January 1, 2023, the Company adopted accounting standards update ("ASU") 2016-13, Financial Instruments-Credit Losses (Topic 326) Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"), using a modified retrospective approach.
 Under ASU 2016-13, for securities in an unrealized loss position, a credit loss is recognized in earnings within realized investment gains (losses) when it is anticipated that the amortized cost will not be recovered. When either: (i) the
 Company has the intent to sell the security; or (ii) it is more likely than not that the Company will be required to sell the security before recovery, the reduction of amortized cost and the loss recognized in earnings is the entire difference
 between the security's amortized cost and estimated fair value. If neither of these conditions exists, the difference between the amortized cost of the security and the present value of projected future cash flows expected to be collected is
 recognized as a credit loss by establishing an ACL with a corresponding charge to earnings in realized investment gains (losses). However, the ACL is limited by the amount that the fair value is less than the amortized cost. This limitation is
 known as the "fair value floor." If the estimated fair value is less than the present value of projected future cash flows expected to be collected, this portion of the decline in value related to other-than-credit factors ("noncredit loss") is
 recorded in OCI.

 Policy

 loans are carried at unpaid principal balance and are fully collateralized by the cash surrender value of the underlying insurance contract. Real estate is carried at historical cost and is evaluated for impairment when circumstances would
 indicate that fair value may be less than carrying value.

 The

 Company holds passive interests in a number of entities that are considered to be variable interest entities ("VIEs") under GAAP guidance. The Company's VIE interests principally consist of interests in limited partnerships and limited
 liability companies formed for the purpose of achieving diversified equity returns, which are included in other invested assets on the balance sheet and are accounted for using the equity method. The Company does not have power over the
 activities that most significantly impact the economic performance of these VIEs and thus is not the primary beneficiary. Therefore, the Company has not consolidated these VIEs. Also included in the Company's VIEs are investments in
 unconsolidated trusts, which are presented on the balance sheet and carried at cost. The Company's involvement with each VIE is limited to its direct ownership interest in the VIE. The Company has no arrangements with any of the VIEs to provide
 other financial support to or on behalf of the VIE. The Company reviews its investments in other invested assets for impairment no less frequently than quarterly and monitors the performance throughout the year. If the Company becomes aware of
 an impairment of an other invested asset at the balance sheet date, it will recognize an impairment by recording a reduction in the carrying value of the other invested asset with a corresponding charge to net investment income.

 Premiums and discounts related to investments are amortized or accreted over the life of the related investment as an adjustment to yield using the
 effective interest method. Dividends and interest income are recognized when earned or declared. The cost of securities sold is based on specific identification. Unrealized gains (losses) in the value of fixed maturities are accounted for as a
 direct increase (decrease) in accumulated other comprehensive income in shareholders' equity, net of deferred tax and, accordingly, have no effect on net income.

 Income Taxes

 Deferred income taxes represent the expected future tax consequences when the reported amounts of assets and liabilities are recovered or paid. They
 arise from differences between the financial reporting and tax basis of assets and liabilities and are adjusted for changes in tax laws and tax rates as those changes are enacted. The provision for income taxes represents the total amount of income
 taxes due related to the current year, plus the change in deferred income taxes during the year. A valuation allowance is recognized if, based on management's assessment of the relevant facts, it is more likely than not that some portion of a
 deferred tax asset will not be realized.

 Earnings Per Common Share

 Basic earnings per common share are based on the weighted average number of common and participating shares outstanding during the relevant period.
 Diluted earnings per common share are based on the weighted average number of common and participating shares outstanding during the relevant period, plus options outstanding, if applicable, using the treasury stock method and the assumed
 conversion of the Series D preferred stock, if dilutive. Unless otherwise indicated, earnings per common share amounts are presented on a diluted basis.

 Cash and Cash Equivalents

 Cash and cash equivalents consist of cash on hand and investments in short-term, highly liquid securities with original maturities of three months
 or less from date of purchase.

 The Company's insurance subsidiaries from time to time purchase reinsurance from unaffiliated insurers and reinsurers to reduce their potential liability on individual risks and to protect against catastrophic losses. In
 a reinsurance transaction, an insurance company transfers, or "cedes," a portion or all of its exposure on insurance policies to a reinsurer. The reinsurer assumes the exposure in return for a portion of the premiums. The ceding of insurance
 does not legally discharge the insurer from primary liability for the full amount of the policies written by it, and the ceding company will incur a loss if the reinsurer fails to meet its obligations under the reinsurance agreement.

 Amounts currently recoverable under reinsurance agreements are included in reinsurance receivables and amounts currently payable are included in other liabilities. Assets and liabilities
 relating to reinsurance agreements with the same reinsurer may be recorded net on the balance sheet, if a right of offset exists within the reinsurance agreement. In the event that reinsurers do not meet their obligations to the Company under
 the terms of the reinsurance agreements, reinsurance recoverable balances could become uncollectible. In such instances, reinsurance recoverable balances are stated net of allowances for uncollectible reinsurance.

 Share-Based Transactions

 For employee and director share-based compensation awards, the Company determines a grant date fair value based on the price of our publicly-traded
 common stock and recognize the related compensation expense, adjusted for actual forfeitures, in the consolidated statement of operations on a straight-line basis over the requisite service period for the entire award. For non-employee share-based
 compensation awards, the Company recognizes the impact during the period of performance, and the fair value of the award is measured as of the date performance is complete, which is the vesting date.

 Treasury Stock

 Treasury stock is reflected as a reduction of shareholders' equity at cost. The Company uses the first-in-first-out ("FIFO") purchase cost to
 determine the cost of treasury stock that is reissued. The Company includes any gains and losses in additional paid-in capital when treasury stock is reissued.

 Recently Issued Accounting Standards

 Adoption of New Accounting Standards

 Reference Rate Reform. In March 2020, the FASB issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ("ASU 2020-04"). This guidance provides optional
 expedients and exceptions for applying GAAP to investments, derivatives, or other transactions that reference the London Interbank Offered Rate (LIBOR) or another reference rate expected to be discontinued because of reference rate reform. Along
 with the optional expedients, the amendments include a general principle that permits an entity to consider contract modifications due to reference reform to be an event that does not require contract re-measurement at the modification date or
 reassessment of a previous accounting determination. Additionally, a company may make a one-time election to sell, transfer, or both sell and transfer debt securities classified as held to maturity that reference a rate affected by reference rate
 reform and that were classified as held to maturity before January 1, 2020. The Company adopted the guidance as of June 30, 2023. The adoption of the guidance had no significant impact on the Company's financial condition and results of
 operations.

 Financial Instruments – Credit Losses. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments
 – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments ("ASU 2016-13"). The updated guidance applies a new credit loss model (current expected credit losses or CECL) for determining credit-related impairments for
 financial instruments measured at amortized cost (including reinsurance recoverables, premium and other receivables) and requires an entity to estimate the credit losses expected over the life of an exposure or pool of exposures. The estimate of
 expected credit losses should consider historical information, current information, as well as reasonable and supportable forecasts, including estimates of prepayments. The expected credit losses, and subsequent adjustments to such losses, are
 recorded through an allowance account that is deducted from the amortized cost basis of the financial asset, with the net carrying value of the financial asset presented on the consolidated balance sheet at the amount expected to be collected.

 The updated guidance also amends the previous other-than-temporary impairment model for available-for-sale debt securities by requiring the
 recognition of impairments relating to credit losses through an allowance account and limits the amount of credit loss to the difference between a security's amortized cost basis and its fair value. In addition, the length of time a security has
 been in an unrealized loss position will no longer impact the determination of whether a credit loss exists.

 The Company adopted the updated guidance as of January 1, 2023. The updated guidance was applied by a cumulative effect adjustment to the opening
 balance of retained earnings as of January 1, 2023, the beginning of the period of adoption. The adoption of this guidance resulted in the recognition of an after-tax cumulative effect adjustment of $ 0.1 million to reflect the impact of recognizing expected credit losses, as compared to incurred credit losses recognized under the previous guidance. This adjustment is
 primarily associated with reinsurance recoverables, premium and other receivables. The cumulative effect adjustment decreased retained earnings as of January 1, 2023 and increased the allowance for estimated uncollectible reinsurance.

 Impact of Adoption on Condensed Consolidated Balance Sheet

 Reinsurance Recoverables

 The following table presents the balances of reinsurance recoverables, net of the allowance for estimated uncollectible reinsurance, at
 January 1, 2023 and December 31, 2023, and the changes in the allowance for estimated uncollectible reinsurance for the year ended December 31, 2023.

 Year ended December 31, 2023

 (in thousands)

 Reinsurance Recoverables,

 Net of Allowance for Estimated

 Uncollectible Reinsurance

 Allowance for Estimated

 Uncollectible Reinsurance

 Balance, beginning of period

 $

 25,913

 $

 —

 Cumulative effect of adoption of updated accounting guidance for credit losses at January 1, 2023

 Current period change for estimated uncollectible reinsurance

 ( 14

)

 Write-offs of uncollectible reinsurance recoverables

 —

 Balance, end of period

 $

 21,103

 $

 Insurance Premium and Other Receivables

 The following table presents the balances of insurance premiums and other, net of the allowance for expected credit losses, at January 1,
 2023 and December 31, 2023, and the changes in the allowance for doubtful accounts/expected credit losses for the year ended December 31, 2023.

 Year ended December 31, 2023

 (in thousands)

 Insurance Premiums and

 Other, Net of Expected Credit

 Allowance for Doubtful

 Accounts/Expected Credit

 Balance, beginning of period

 $

 15,386

 $

 Cumulative effect of adoption of updated accounting guidance for credit losses at January 1, 2023

 —

 Current period change for expected credit losses

 Write-offs of uncollectible insurance premiums and other receivables

 —

 Balance, end of period

 $

 23,690

 $

 Future Adoption of New Accounting Standards

 Accounting for Long-Duration Contracts. In August 2018, the FASB issued ASU No. 2018-12, Financial
 Services —Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts ("ASU 2018-12"). This guidance (1) improves the timeliness of recognizing changes in the liability for future policy benefits and modifies
 the rate used to discount future cash flows, (2) simplifies and improves the accounting for certain market-based options or guarantees associated with deposit (or account balance) contracts, (3) simplifies the amortization of deferred
 acquisition costs, and (4) improves the effectiveness of the required disclosures. ASU 2018-12 is effective for annual reporting periods beginning after December 15, 2024 and interim periods beginning after December 15, 2025, although earlier
 adoption is permitted. The Company is currently evaluating the new guidance, but has not yet determined the method. The Company will adopt on January 1, 2025.

 Segment Reporting. In November 2023, the FASB issued ASU No. 2023-07, Segment Reporting- An Amendment for Improvements to Reportable Segment Disclosures (Topic 280). The amendments in ASU 2023-07 improve reportable segment
 disclosure requirements through enhanced disclosures about significant segment expenses. The amendment; introduces a new requirement to disclose significant segment expenses regularly provided to the chief operating decision maker (CODM);
 extends certain annual disclosures to interim periods; clarifies single reportable segment entities must apply ASC 280 in its entirety, permits more than one measure of segment profit or loss to be reported under certain conditions, and
 requires disclosure of the title and position of the CODM. The amendments in this update do not change or remove existing disclosure requirements. The Update is effective for fiscal years beginning after December 15, 2023, and interim periods
 within fiscal years beginning after December 15, 2024, although early adoption is permitted. The Company is evaluating the new guidance and any effect it will have on the Company's financials.

 Income Taxes. In December 2023, the FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The amendment requires that all entities disclose on an annual basis the following information about income
 taxes paid; the amount of income taxes paid (net of refunds received) disaggregated by federal (national), state, and foreign taxes; and the amount of income taxes paid (net of refunds received) disaggregated by individual jurisdictions in
 which income taxes paid (net of refunds received) is equal to or greater than 5% of total income taxes paid (net of refunds received). All entities also are required to disclose; income (or loss) from continuing operations before income tax
 expense (or benefit) disaggregated between domestic and foreign; and income tax expense (or benefit) from continuing operations disaggregated by federal (national), state, and foreign. The ASU, which also includes certain other amendments to
 improve the effectiveness of income tax disclosures, is effective for public business entities for annual periods beginning after Dec. 15, 2024. The Company is evaluating the new guidance and any effect it will have on the Company's financials.

 Use of Estimates in the Preparation of Financial Statements

 The preparation of financial statements and related disclosures in conformity with GAAP requires management to make estimates and assumptions that
 affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reporting period. Significant estimates and assumptions are used
 in developing and evaluating deferred income taxes, deferred acquisition costs, insurance reserves, investments, and receivables, among others, and actual results could differ materially from management's estimates.

 Note 2.

 The following tables set forth the estimated fair value, gross unrealized gains, gross unrealized losses, allowance for credit losses and cost or
 amortized cost of the Company's investments in fixed maturities and equity securities, aggregated by type and industry, as of December 31, 2023 and December 31, 2022.

 Fixed maturities were comprised of the following:

 2023

 Gross

 Gains

 Gross

 Allowance

 for

 Credit

 Amortized

 Cost

 Fixed maturities:

 Bonds:

 U.S. Treasury securities and obligations of U.S. Government agencies and authorities

 $

 50,059

 $

 $

 4,944

 $

 —

 $

 54,940

 Obligations of states and political subdivisions

 8,106

 1,424

 —

 9,515

 Corporate securities:

 Utilities and telecom

 21,309

 2,582

 —

 23,748

 Financial services

 59,584

 4,931

 —

 63,955

 Other business – diversified

 34,386

 2,940

 —

 36,923

 Other consumer – diversified

 44,570

 4,870

 —

 49,353

 Total corporate securities

 159,849

 1,193

 15,323

 —

 173,979

 Redeemable preferred stocks:

 Other consumer – diversified

 —

 —

 Total redeemable preferred stocks

 —

 —

 Total fixed maturities

 $

 $

 1,284

 $

 21,691

 $

 —

 $

 238,626

 2022

 Gross

 Gains

 Gross

 Amortized

 Cost

 Fixed maturities:

 Bonds:

 U.S. Treasury securities and obligations of U.S. Government agencies and authorities

 $

 44,412

 $

 $

 5,926

 $

 50,333

 Obligations of states and political subdivisions

 9,187

 1,702

 10,885

 Corporate securities:

 Utilities and telecom

 22,090

 3,299

 25,269

 Financial services

 59,054

 7,085

 65,742

 Other business – diversified

 31,058

 4,689

 35,586

 Other consumer – diversified

 42,705

 6,089

 48,759

 Total corporate securities

 154,907

 21,162

 175,356

 Redeemable preferred stocks:

 Other consumer – diversified

 —

 Total redeemable preferred stocks

 —

 Total fixed maturities

 $

 $

 $

 28,790

 $

 236,766

 Bonds having an amortized cost of $ 14,647
 and $ 12,333 and included in the tables above were on deposit with insurance regulatory authorities at December 31, 2023 and 2022,
 respectively, in accordance with statutory requirements. Additionally, bonds having an amortized cost of $ 9,584 and $ 7,221 and included in the tables above were pledged as collateral to FHLB at December 31, 2023 and 2022, respectively.

 2023

 Gross

 Gains

 Gross

 Cost

 Equity securities:

 Common and non-redeemable preferred stocks:

 Financial services

 —

 Communications

 8,489

 3,856

 —

 4,633

 Total equity securities

 $

 9,413

 $

 4,477

 $

 —

 $

 4,936

 2022

 Gross

 Gains

 Gross

 Cost

 Equity securities:

 Common and non-redeemable preferred stocks:

 Financial services

 —

 Communications

 10,772

 6,139

 —

 4,633

 Total equity securities

 $

 $

 6,655

 $

 —

 $

 4,907

 The carrying value and amortized cost of the Company's investments in fixed maturities at December 31, 2023 and 2022 by contractual maturity were as follows. Actual maturities may differ from contractual maturities because issuers may call or prepay
 obligations with or without call or prepayment penalties.

 2023

 2022

 Carrying

 Value

 Amortized

 Cost

 Carrying

 Value

 Amortized

 Cost

 Due in one year or less

 $

 1,715

 $

 1,750

 $

 3,776

 $

 3,797

 Due after one year through five years

 60,423

 62,423

 40,150

 42,174

 Due after five years through ten years

 33,596

 36,752

 44,044

 49,711

 Due after ten years

 86,857

 97,984

 87,719

 103,095

 Asset backed securities

 35,628

 39,717

 33,040

 37,989

 Totals

 $

 $

 238,626

 $

 $

 236,766

 The following tables present the Company's unrealized loss aging for securities by type and length of time the security was in a continuous
 unrealized loss position as of December 31, 2023 and 2022.

 2023

 Less than 12 months

 12 months or longer

 Total

 Fair

 Value

 Fair

 Value

 Fair

 Value

 U.S. Treasury securities and obligations of U.S. Government agencies and authorities

 $

 5,194

 $

 $

 39,476

 $

 4,907

 $

 44,670

 $

 4,944

 Obligations of states and political subdivisions

 1,145

 5,936

 1,421

 7,081

 1,424

 Corporate securities

 138,283

 15,310

 138,822

 15,323

 Total temporarily impaired securities

 $

 6,878

 $

 $

 183,695

 $

 21,638

 $

 190,573

 $

 21,691

 2022

 Less than 12 months

 12 months or longer

 Total

 Fair

 Value

 Fair

 Value

 Fair

 Value

 U.S. Treasury securities and obligations of U.S. Government agencies and authorities

 $

 23,763

 $

 2,410

 $

 19,259

 $

 3,516

 $

 43,022

 $

 5,926

 Obligations of states and political subdivisions

 8,183

 1,702

 —

 —

 8,183

 1,702

 Corporate securities

 127,928

 16,214

 14,514

 4,948

 142,442

 21,162

 Total temporarily impaired securities

 $

 159,874

 $

 20,326

 $

 33,773

 $

 8,464

 $

 193,647

 $

 28,790

 Analysis of Securities in Unrealized Loss Positions

 As
 of December 31, 2023 and 2022, there were 311 and 237 securities, respectively, in an unrealized loss position which primarily included certain of the Company's investments in fixed maturities within the utilities and telecom, financial services, other
 diversified business and other diversified consumer sectors. The unrealized losses on the Company's fixed maturity securities investments have been primarily related to general market changes in interest rates and/or the levels of credit spreads
 rather than specific concerns with the issuer's ability to pay interest and repay principal.

 For
 any of its fixed maturity securities with significant declines in fair value, the Company performs detailed analyses to identify whether the drivers of the declines are due to general market drivers, such as the recent increases in interest rates,
 or due to credit-related factors. Identifying the drivers of the declines in fair value helps to align and allocate the Company's resources to securities with real credit-related concerns that could impact the ultimate collection of principal and
 interest. For any significant declines in fair value determined to be non-interest rate or market related, the Company performs a more focused review of the related issuers' specific credit profile.

 For
 corporate issuers, the Company evaluates their assets, business profile including industry dynamics and competitive positioning, financial statements and other available financial data. For non-corporate issuers, the Company analyzes all reasonably
 available sources of credit support, including issuer-specific factors. The Company utilizes information available in the public domain and, for certain private placement issuers, from consultations with the issuers directly. The Company also
 considers ratings from Nationally Recognized Statistical Rating Organizations (NRSROs), as well as the specific characteristics of the security it owns including seniority in the issuer's capital structure, covenant protections, or other relevant
 features. From these reviews, the Company evaluates the issuers' continued ability to service the Company's investment through payment of interest and principal.

 Assuming no credit-related factors develop, unrealized gains and losses on fixed maturity securities are expected to diminish as investments near maturity. Based on its credit
 analysis, the Company believes that the issuers of its fixed maturity investments in the sectors shown in the table above have the ability to service their obligations to the Company. In addition, the Company does not intend to sell the
 investments and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.

 However, from time to time the Company identifies certain available-for-sale fixed maturity securities where the amortized cost basis exceeds the present value of the cash flows
 expected to be collected due to credit related factors and as a result, a credit allowance will be estimated. The Company had no ACL
 on its available-for-sale fixed maturities as of December 31, 2023. The Company did no t record any other than temporary impairments as
 of December 31, 2022.

 Investment income was earned from the following sources:

 2023

 2022

 Fixed maturities

 $

 9,333

 $

 9,141

 Equity securities

 Other

 10,311

 10,197

 Investment expenses

 Net investment income

 $

 $

 9,932

 A summary of realized investment gains (losses) follows:

 2023

 Fixed

 Maturities

 Equity

 Securities

 Other

 Invested Assets

 Total

 Gains

 $

 $

 —

 $

 —

 $

 —

 —

 —

 —

 $

 $

 —

 $

 —

 $

 2022

 Fixed

 Maturities

 Equity

 Securities

 Other

 Invested Assets

 Total

 Gains

 $

 $

 —

 $

 $

 ( 52

)

 —

 ( 20

)

 ( 72

)

 Realized investment gains (losses), net

 $

 $

 —

 $

 ( 19

)

 $

 Proceeds from the sales of available-for-sale fixed maturities were as follows:

 2023

 2022

 Sales proceeds

 $

 5,035

 $

 3,649

 Gross gains

 Gross losses

 —

 —

 Proceeds from the sales of equity securities were as follows:

 2023

 2022

 Sales proceeds

 $

 $

 Gross gains

 —

 —

 Gross losses

 —

 —

 Proceeds from the sales of other invested assets were as follows:

 2023

 2022

 Sales proceeds

 $

 —

 $

 Gross gains

 —

 Gross losses

 —

 ( 20

)

 Sales of available-for-sale securities in 2023 and 2022 were primarily a result of improving the overall risk versus return profile of the
 portfolio. In addition, the Company sold its interest in a certain limited liability company held as other invested assets to a third-party in 2022.

 The following table presents the portion of unrealized gains (losses) related to equity securities still held for the years ended December 31, 2023
 and 2022.

 2023

 2022

 Net realized and unrealized gains (losses) recognized during the period on equity securities

 $

 ( 2,177

)

 $

 ( 7,562

)

 Less: Net realized gains recognized during the period on equity securities sold during the period

 —

 —

 Unrealized gains (losses) on equity securities, net

 $

 ( 2,177

)

 $

 ( 7,562

)

 The Company's bond portfolio included 99 %
 investment grade securities, as defined by the NAIC, at December 31, 2023 and 2022.

 Variable Interest Entities

 The Company holds passive interests in a number of entities that are considered to be variable interest entities ("VIEs") under GAAP guidance. The
 Company's VIE interests principally consist of interests in limited partnerships and limited liability companies formed for the purpose of achieving diversified equity returns. The Company's VIE interests, carried as a part of other invested
 assets, totaled $ 6,381 and $ 5,386
 at December 31, 2023 and 2022, respectively. The Company's VIE interests, carried as a part of investment in unconsolidated trusts, totaled $ 1,238
 at December 31, 2023 and 2022.

 The Company does not have power over the activities that most significantly impact the economic performance of these VIEs and thus is not the
 primary beneficiary. Therefore, the Company has not consolidated these VIEs. The Company's involvement with each VIE is limited to its direct ownership interest in the VIE. The Company has no arrangements with any of the VIEs to provide other
 financial support to or on behalf of the VIE. The Company's maximum loss exposure relative to these investments was limited to the carrying value of the Company's investment in the VIEs, which amount to $ 7,619 and $ 6,624, at December 31, 2023 and 2022, respectively. As
 of December 31, 2023 and 2022, the Company had outstanding commitments totaling $ 4,518 and $ 5,872, respectively, whereby the Company is committed to fund these investments and may be called by the partnership during the commitment period to fund the purchase of new
 investments and partnership expenses. The

 reduction in the Company's outstanding commitments was a result of an additional investment of $ 1,354 in the partnership.

 Note 3.

 Disclosures About Fair Value of Financial Instruments

 The estimated fair values have been determined by the Company using available market information from various market sources and appropriate
 valuation methodologies as of the respective dates. However, considerable judgment is necessary to interpret market data and to develop the estimates of fair value. Although management is not aware of any factors that would significantly affect
 the estimated fair value amounts, the estimates presented herein are not necessarily indicative of the amounts which the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies
 may have a material effect on the estimated fair value amounts.

 The following describes the fair value hierarchy and provides information as to the extent to which the Company uses fair value to measure the
 value of its financial instruments and information about the inputs used to value those financial instruments. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three broad levels.

 Level 1

 Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company's financial instruments valued using Level 1 criteria
 include cash equivalents and exchange traded common stocks.

 Level 2

 Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company's financial instruments valued using Level 2 criteria include significantly most of its
 fixed maturities, which consist of U.S. Treasury securities, U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturities, as well as its non-redeemable preferred stocks. In
 determining fair value measurements of its fixed maturities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized pricing services and broker/dealers.
 Prices for the majority of the Company's Level 2 fixed maturities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize models where the significant inputs are observable
 (e.g. interest rates, yield curves, prepayment speeds, default rates, loss severities) or can be corroborated by observable market data.

 Level 3

 Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily
 observable from objective sources. With little or no observable market, the determination of fair values uses considerable judgment and represents the Company's best estimate of an amount that could be realized in a market exchange for
 the asset or liability. The Company's financial instruments valued using Level 3 criteria consist of one equity security. As of December 31, 2023 and December 31, 2022, the value of the equity security valued using Level 3 criteria was $ 185 and $ 156, respectively.
 The equity security is not traded and is valued at cost. The use of different criteria or assumptions regarding data may have yielded materially different valuations.

 Recurring Fair Value Measurements

 Cash Equivalents. The carrying amount approximates fair value
 due to the short-term nature of the instruments.

 Fixed Maturities and Common and Non-Redeemable Preferred Stocks. The

 carrying amount is determined from publicly quoted market prices. Certain fixed maturities do not have publicly quoted values and consist solely of issuances of pooled debt obligations of multiple, smaller financial services companies. They are
 not actively traded and valuation techniques used to measure fair value are based on future estimated cash flows discounted at reasonable estimated rates of interest. Other qualitative and quantitative information is also considered, as
 applicable.

 Nonrecurring Fair Value Measurements

 Non-publicly Traded Invested Assets. The fair value of
 investments in certain limited partnerships which are included in other invested assets on the consolidated balance sheet were determined by officers of those limited partnerships.

 Policy Loans. Policy loans, which are categorized as Level 3
 fair value measurements, are carried at the unpaid principal balances.

 Junior Subordinated Debentures. The fair value is estimated
 based on observable interest rates and yields for debt instruments having similar characteristics.

 As of December 31, 2023, financial instruments carried at fair value were measured on a recurring basis as summarized below:

 Assets:

 Quoted Prices in

 Active Markets

 for Identical Assets

 (Level 1)

 Significant

 Other Observable

 Inputs

 (Level 2)

 Significant

 Unobservable

 Inputs

 (Level 3)

 Total

 Fixed maturities

 $

 —

 $

 $

 —

 $

 Equity securities

 9,228

 —

 9,413

 Cash equivalents

 14,834

 —

 —

 14,834

 Total

 $

 24,062

 $

 $

 $

 242,466

 As of December 31, 2022, financial instruments carried at fair value were measured on a recurring basis as summarized below:

 Assets:

 Quoted Prices in

 Active Markets

 for Identical Assets

 (Level 1)

 Significant

 Other Observable

 Inputs

 (Level 2)

 Significant

 Unobservable

 Inputs

 (Level 3)

 Total

 Fixed maturities

 $

 —

 $

 $

 —

 $

 Equity securities

 11,406

 —

 Cash equivalents

 18,861

 —

 —

 18,861

 Total

 $

 30,267

 $

 $

 $

 239,152

 The following table sets forth the carrying amount, estimated fair value and level within the fair value hierarchy of the Company's financial
 instruments as of December 31, 2023 and 2022.

 Level in

 2023

 2022

 Hierarchy (1)

 Carrying

 Carrying

 Assets:

 Cash and cash equivalents

 Level 1

 $

 28,301

 $

 28,301

 $

 $

 Fixed maturities

 Level 2

 Equity securities

 (1)

 9,413

 9,413

 Policy loans

 Level 3

 1,778

 1,778

 1,759

 1,759

 Liabilities:

 Junior subordinated debentures, net

 Level 2

 33,670

 33,810

 Revolving credit facility

 Level 2

 3,019

 3,019

 2,009

 2,009

 (1)

 See the aforementioned information for a description of the fair value hierarchy as well
 as a disclosure of levels for classes of these financial assets.

 Note 4.

 Deferred Policy Acquisition Costs

 The following table presents a rollforward of deferred policy acquisition costs by segment for the years ended December 31.

 2023

 2022

 Deferred policy acquisition costs:

 $

 2,401

 $

 39,880

 $

 2,390

 $

 36,308

 Capitalization

 8,689

 9,320

 10,161

 12,867

 Amortization

 ( 8,390

)

 ( 8,050

)

 ( 10,150

)

 ( 9,295

)

 $

 2,700

 $

 41,150

 $

 2,401

 $

 39,880

 Note 5.

 Internal-Use Software

 On March 3, 2021, the Company entered into a hosting arrangement through a service contract with a third party software
 solutions vendor to provide a suite of policy, billing, claim, and customer management services. The software is managed, hosted, supported, and delivered as a cloud-based software service product offering (software-as-a-service). The initial
 term of the arrangement is five years from the effective date with a renewal term of an additional five years.

 Service fees related to the hosting arrangement are recorded as an expense in the Company's condensed consolidated
 statement of operations as incurred. Implementation expenses incurred related to third party professional and consulting services have been capitalized. The Company will begin amortizing, on a straight-line basis over the expected ten year term of the hosting arrangement, when the software is substantially ready for its intended use. The Company incurred and capitalized
 implementation costs of $ 1,545 and $ 2,522
 during the years ended December 31, 2023 and 2022, respectively. The Company has capitalized $ 4,567 and $ 3,022 in implementation costs in other assets in its condensed consolidated balance sheet as of December 31, 2023 and 2022, respectively. The Company
 expects the software will be substantially ready for its intended use during 2024. Accordingly, the Company has no t recorded any
 amortization expense related to software implementation costs for years ended December 31, 2023 and 2022.

 Note 6.

 Insurance Reserves and Policyholder Funds

 The following table presents the Company's reserves for life, accident and health, and property and casualty losses, claims and loss adjustment
 expenses at December 31, 2023 and 2022.

 Amount of

 Insurance In Force, Net

 2023

 2022

 2023

 2022

 Future policy benefits

 Life insurance policies:

 Ordinary life and annuities

 $

 50,040

 $

 50,660

 $

 172,907

 $

 186,863

 Group life

 11,917

 2,533

 633,017

 474,150

 61,957

 53,193

 $

 805,924

 $

 661,013

 Accident and health insurance policies

 30,538

 32,371

 92,495

 85,564

 Unearned premiums

 31,317

 28,348

 Losses, claims and loss adjustment expenses

 87,478

 87,484

 Other policy liabilities

 1,132

 1,255

 Total insurance reserves and policyholder funds

 $

 212,422

 $

 202,651

 Annualized premiums for accident and health insurance policies were $ 84,127 and $ 89,471 at December 31, 2023 and 2022, respectively.

 Future Policy Benefits

 Liabilities for future benefits on life insurance policies and accident and health insurance policies are based on assumed investment yields,
 mortality rates, disablement rates, benefit utilization rates, and lapse rates after giving effect to possible risks of unexpected adverse claim experience. The mortality, disablement rates, benefit utilization rates, and lapse assumptions are
 based upon the Company's experience and incorporate a margin for adverse experience development. These assumptions are modified as necessary to reflect anticipated trends and are generally established at contract inception. The interest rates
 assumed, which reflect future investment yields at the time policies are issued, are generally: (i) 2.5 % to 5.5 % for issues prior to 1977, (ii) 5.5 % to 7.0 % for 1977 through 1979 issues, (iii) 9.0 %
 for 1980 through 1987 issues, (iv) 5.0 %
 to 7.0 % for 1988 through 2009
 issues, and (v) 3.0 % to 4.0 %
 for 2010 through 2023 issues.

 Loss and Claim Reserves

 Loss and claim reserves represent estimates of projected ultimate losses and are based upon: (a) management's estimate of ultimate liability and
 claims adjusters' evaluations for unpaid claims reported prior to the close of the accounting period, (b) estimates of incurred but not reported ("IBNR") claims based on past experience, and (c) estimates of loss adjustment expenses. The
 estimated liability is periodically reviewed by management and updated, with changes to the estimated liability recorded in the statement of operations in the year in which such changes are known.

 Activity in the liability for unpaid loss and claim reserves is summarized as follows:

 2023

 2022

 Balance at January 1

 $

 87,484

 $

 85,620

 Less: Reinsurance recoverable on unpaid losses

 ( 17,647

)

 ( 17,690

)

 Net balance at January 1

 69,837

 67,930

 Incurred related to:

 Current year

 113,246

 125,754

 Prior years

 1,418

 (1)

 ( 4,228

) (2)

 Total incurred

 114,664

 121,526

 Paid related to:

 Current year

 67,484

 82,002

 Prior years

 44,217

 37,617

 Total paid

 111,701

 119,619

 Net balance at December 31

 72,800

 69,837

 Plus: Reinsurance recoverable on unpaid losses

 14,678

 17,647

 Balance at December 31

 $

 87,478

 $

 87,484

 (1)

 Prior years' development was primarily the result of unfavorable development in the automobile
 liability line of business in the property and casualty operations due to inflationary factors.

 (2)

 Prior years' development was primarily the result of favorable development in the Medicare
 supplement line of business in the life and health operations, as well as favorable development in the surety line of business in the property and casualty operations.

 Following is a reconciliation of total incurred losses to total insurance benefits and losses incurred:

 2023

 2022

 Total incurred losses

 $

 114,664

 $

 121,526

 Cash surrender value and matured endowments

 1,323

 1,598

 Benefit reserve changes

 6,513

 Total insurance benefits and losses incurred

 $

 $

 Liability for Unpaid Losses, Claims and Loss Adjustment Expenses

 The following is information, by significant product lines, about incurred and paid claims development as of December 31, 2023, net of
 reinsurance, as well as the cumulative number of reported claims and the total of IBNR reserves plus expected development on reported claims included within the net incurred claims amounts. The information presented for the years ended December
 31, 2015 and prior is presented as supplementary information and is unaudited.

 Medicare Supplement

 As of December 31,

 2023

 Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of

 IBNR

 Reported Claims

 2014

 2015

 2016

 2017

 2018

 2019

 2020

 2021

 2022

 2023

 2014

 $

 57,179

 $

 56,938

 $

 56,981

 $

 56,981

 $

 $

 56,977

 $

 $

 $

 $

 $

 —

 2015

 55,482

 54,939

 54,993

 54,990

 54,984

 —

 2016

 58,849

 59,851

 63,226

 63,225

 —

 1,037

 2017

 67,960

 69,655

 69,643

 69,635

 69,632

 —

 1,512

 2018

 79,140

 80,404

 80,361

 80,357

 80,351

 80,348

 —

 2,052

 2019

 88,765

 87,028

 86,988

 86,986

 86,980

 —

 2,246

 2020

 75,857

 75,715

 75,730

 75,730

 1,853

 2021

 65,267

 61,579

 61,785

 1,771

 2022

 58,777

 56,047

 2,103

 2023

 48,367

 11,979

 1,864

 $

 654,071

 Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance

 2014

 2015

 2016

 2017

 2018

 2019

 2020

 2021

 2022

 2023

 2014

 $

 48,024

 $

 56,938

 $

 56,981

 $

 56,981

 $

 $

 56,977

 $

 $

 $

 $

 2015

 45,430

 54,876

 54,993

 54,990

 54,984

 2016

 49,165

 59,747

 63,226

 63,225

 2017

 57,696

 69,517

 69,643

 69,635

 2018

 66,565

 80,222

 80,361

 80,355

 80,351

 80,348

 2019

 72,333

 86,856

 86,978

 86,985

 86,980

 2020

 63,129

 75,527

 75,710

 75,715

 2021

 50,197

 61,350

 61,733

 2022

 46,111

 55,808

 2023

 36,388

 $

 641,787

 $

 12,284

 The cumulative number of reported claims for the Medicare Supplement line of business is the number of distinct claims incurred and submitted to
 the Centers for Medicare and Medicaid Services (or its designee) for payment in the given year. Multiple payments on the same claim are not counted in the claim frequency data. Estimated ultimate claims incurred, using claims data reported during
 each month of any given year, are calculated using the chain ladder method modified to reflect seasonality by trend-adjusting expected claims for the most recent four-month period prior to the statement date. Additional adjustments to the
 estimated ultimate claims incurred are then applied to account for seasonal changes in claim experience and changes in the rate of claim processing. The IBNR is calculated as the estimated ultimate claims less the total of paid claims through the
 valuation date and claims in the course of settlement as of the valuation date. Thirty-six months of loss data are used to develop the
 estimated ultimate incurred claims. For other accident and health products that have very small claim volumes, similar approaches are used and modified to reflect the unique aspects of the products.

 Automobile Liability

 As of December 31,

 2023

 Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of

 IBNR

 Reported

 Claims

 2014

 2015

 2016

 2017

 2018

 2019

 2020

 2021

 2022

 2023

 2014

 $

 20,812

 $

 21,881

 $

 22,041

 $

 22,353

 $

 21,682

 $

 22,080

 $

 22,100

 $

 22,125

 $

 22,165

 $

 22,095

 $

 —

 3,560

 2015

 18,521

 19,857

 20,017

 20,007

 20,086

 20,680

 20,849

 20,955

 21,021

 —

 3,537

 2016

 20,549

 21,275

 21,846

 22,388

 22,245

 22,310

 22,448

 22,448

 —

 3,862

 2017

 22,179

 24,212

 23,766

 25,180

 26,009

 26,153

 26,231

 3,813

 2018

 24,284

 25,682

 27,338

 30,013

 30,464

 31,135

 3,651

 2019

 25,241

 24,045

 25,724

 28,042

 28,513

 3,606

 2020

 22,416

 16,442

 20,137

 21,164

 1,010

 2,517

 2021

 25,887

 21,172

 24,957

 1,899

 2,774

 2022

 28,860

 27,293

 3,093

 2,845

 2023

 33,266

 16,714

 2,558

 $

 258,123

 Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance

 2014

 2015

 2016

 2017

 2018

 2019

 2020

 2021

 2022

 2023

 2014

 $

 6,822

 $

 13,807

 $

 17,554

 $

 20,177

 $

 20,878

 $

 21,735

 $

 21,813

 $

 21,786

 $

 21,958

 $

 22,095

 2015

 6,226

 11,878

 14,938

 17,612

 19,557

 20,234

 20,726

 20,904

 21,021

 2016

 6,796

 13,141

 16,397

 19,613

 21,408

 21,809

 22,448

 22,448

 2017

 7,401

 16,317

 20,221

 22,778

 25,023

 25,712

 26,222

 2018

 6,989

 15,647

 21,121

 24,662

 27,671

 29,201

 2019

 7,305

 14,694

 19,384

 22,868

 26,126

 2020

 5,172

 9,941

 14,693

 18,133

 2021

 6,242

 13,918

 19,230

 2022

 7,023

 18,010

 2023

 9,068

 $

 211,554

 $

 46,569

 Automobile Physical Damage

 As of December 31, 2023

 Incurred Losses, Claims and Allocated Loss Adjustment Expenses,

 Net of Reinsurance

 IBNR

 Reported

 Claims

 2019

 2020

 2021

 2022

 2023

 2019

 $

 8,526

 $

 8,026

 $

 7,914

 $

 7,881

 $

 7,873

 $

 1,495

 2020

 10,288

 10,080

 10,047

 10,024

 1,642

 2021

 14,296

 13,385

 13,305

 1,900

 2022

 10,962

 10,648

 1,756

 2023

 6,460

 1,401

 $

 48,310

 Cumulative Paid Losses, Claims and Allocated Loss Adjustment

 Expenses, Net of Reinsurance

 2019

 2020

 2021

 2022

 2023

 2019

 $

 6,360

 $

 8,005

 $

 7,906

 $

 7,867

 $

 7,866

 2020

 8,347

 9,952

 10,008

 9,992

 2021

 11,993

 13,277

 13,257

 2022

 8,475

 10,368

 2023

 5,397

 $

 46,880

 $

 1,430

 General Liability

 As of December 31,

 2023

 Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of

 IBNR

 Reported

 Claims

 2014

 2015

 2016

 2017

 2018

 2019

 2020

 2021

 2022

 2023

 2014

 $

 3,744

 $

 $

 $

 $

 $

 $

 $

 $

 $

 $

 2015

 4,421

 1,037

 1,227

 1,044

 —

 2016

 3,119

 1,148

 —

 2017

 1,490

 —

 2018

 1,656

 —

 2019

 1,916

 2020

 2,223

 ( 66

)

 2021

 2,567

 1,329

 1,328

 2022

 2,770

 2,380

 2023

 2,887

 1,906

 $

 10,831

 Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance

 2014

 2015

 2016

 2017

 2018

 2019

 2020

 2021

 2022

 2023

 2014

 $

 $

 $

 $

 $

 $

 $

 $

 $

 $

 2015

 2016

 2017

 2018

 2019

 2020

 2021

 2022

 1,169

 2023

 $

 5,989

 All outstanding liabilities before 2014, net of reinsurance

 $

 5,183

 As of December 31,

 2023

 Incurred Losses, Claims and Allocated Loss Adjustment Expenses, Net of

 IBNR

 Reported

 Claims

 2014

 2015

 2016

 2017

 2018

 2019

 2020

 2021

 2022

 2023

 2014

 $

 3,214

 $

 3,130

 $

 2,990

 $

 2,760

 $

 2,685

 $

 2,617

 $

 2,818

 $

 2,782

 $

 2,852

 $

 2,592

 $

 2015

 1,902

 1,630

 1,400

 1,359

 1,406

 1,310

 1,307

 1,280

 1,279

 —

 2016

 3,314

 1,812

 1,865

 1,876

 1,865

 1,678

 1,670

 1,666

 —

 2017

 4,677

 3,671

 3,799

 3,629

 3,514

 3,440

 3,448

 2018

 3,528

 1,938

 1,381

 —

 2019

 2,130

 2020

 2,263

 —

 2021

 2,936

 1,455

 1,497

 —

 2022

 3,202

 2,339

 2023

 2,634

 1,590

 $

 17,172

 Cumulative Paid Losses, Claims and Allocated Loss Adjustment Expenses, Net of Reinsurance

 2014

 2015

 2016

 2017

 2018

 2019

 2020

 2021

 2022

 2023

 2014

 $

 1,331

 $

 2,327

 $

 2,727

 $

 2,739

 $

 2,664

 $

 2,593

 $

 2,562

 $

 2,562

 $

 2,568

 $

 2,570

 2015

 1,127

 1,125

 1,128

 1,271

 1,273

 1,279

 1,279

 2016

 1,054

 1,732

 1,772

 1,873

 1,862

 1,677

 1,670

 1,666

 2017

 1,971

 3,255

 3,523

 3,545

 3,442

 3,402

 3,400

 2018

 1,157

 1,454

 1,361

 2019

 2020

 2021

 1,496

 2022

 2,191

 2023

 $

 14,352

 All outstanding liabilities before 2014, net of reinsurance

 $

 2,853

 For the property and casualty lines of business, the number of claims presented above equals the number of occurrences by type of claim reported
 to the Company. The number of claims reported during a given year corresponds to the number of claims records opened during the year. Frequency information is maintained on a cumulative basis by accident year by line of business. For automobile
 claims, a claim count is separately maintained for bodily injury, property damage and physical damage claims. The Company has consistently monitored claim frequency on this basis, and believes this provides more meaningful information than using
 claimant count which can change over the course of settling a claim.

 In general, when a claim is reported, claims representatives establish a "case reserve" for the estimated amount of the ultimate payment based on
 the known information of the claim at that time. Claims managers review and monitor all property and casualty claims in excess of $ 25,000.
 As new information becomes available or payments are made on a claim, the case reserve is adjusted to reflect the revised estimate of the ultimate amount to be paid out. Estimates and assumptions pertaining to individual claims are based on
 complex and subjective judgments and subject to change at any time as new information becomes available.

 In addition to case reserves, IBNR reserves are established to provide for claims which have not been reported to the Company as of the reporting
 date as well as potential adverse development on known case reserves. IBNR reserve estimates are derived through a number of analytical techniques. Actuarial data is analyzed by line of business, coverage and accident year. Qualitative factors
 are also considered in determining IBNR reserves and include such factors as judicial decisions, general economic trends such as inflation, changes in policy forms, and underwriting changes. Reserves are reviewed quarterly and any indicated
 adjustments are made.

 Because of the inherent uncertainties in establishing both case and IBNR reserves, ultimate loss experience may prove better or worse than
 indicated by the combined claim reserves. Adjustments to claim reserves are reflected in the period recognized and could increase or decrease earnings for the period.

 The following is supplementary information about average historical claims duration as of December 31, 2023.

 Average Annual Percentage Payout of Incurred Claims by Age, Net of Reinsurance (Unaudited)

 Reserve Line

 1 st Year

 2 nd Year

 3 rd Year

 4 th Year

 5 th Year

 6 th Year

 7 th Year

 8 th Year

 9 th Year

 10 th Year

 Medicare Supplement

 81.9

 %

 17.1

 %

 0.2

 %

 0.0

 %

 0.0

 %

 0.0

 %

 0.0

 %

 0.0

 %

 0.0

 %

 0.0

 %

 Automobile Liability

 26.9

 %

 29.8

 %

 17.3

 %

 12.6

 %

 8.3

 %

 3.3

 %

 1.9

 %

 0.2

 %

 0.7

 %

 0.6

 %

 Automobile Physical Damage

 83.5

 %

 16.1

 %

 - 0.3

 %

 - 0.3

 %

 0.0

 %

 0.0

 %

 0.0

 %

 0.0

 %

 0.0

 %

 0.0

 %

 General Liability

 21.9

 %

 22.2

 %

 21.2

 %

 14.6

 %

 13.1

 %

 5.7

 %

 1.4

 %

 0.2

 %

 0.0

 %

 0.6

 %

 50.4

 %

 41.5

 %

 14.5

 %

 - 10.6

 %

 - 5.1

 %

 - 1.1

 %

 - 0.4

 %

 0.1

 %

 0.1

 %

 0.1

 %

 The reconciliation of the net incurred and paid claims development tables to the liability for losses, claims and loss adjustment expenses is as
 follows:

 December 31, 2023

 Net outstanding liabilities

 Medicare Supplement

 $

 12,284

 Automobile Liability

 46,569

 Automobile Physical Damage

 1,430

 General Liability

 5,183

 2,853

 Other short-duration insurance lines

 2,391

 Liabilities for unpaid losses, claims and loss adjustment expenses, net of reinsurance

 70,710

 Reinsurance recoverable on unpaid losses:

 Medicare Supplement

 8,263

 Automobile Liability

 3,870

 Automobile Physical Damage

 General Liability

 2,242

 Other short-duration insurance lines

 —

 Total reinsurance recoverable on unpaid losses

 14,678

 Unallocated claims adjustment expenses

 2,090

 Total gross liability for unpaid losses, claims and loss adjustment expenses

 $

 87,478

 Note 7.

 In accordance with general practice in the insurance industry, portions of the life, property and casualty insurance written by the Company are
 reinsured; however, the Company remains liable with respect to reinsurance ceded should any reinsurer be unable or unwilling to meet its obligations. Approximately 99.7 % of the Company's reinsurance recoverables were due from a single reinsurer as of December 31, 2023. Reinsurance recoverables of $ 21,041 were due from General Re Corporation, rated "AA+" by Standard & Poor's and "A++" (Superior) by A.M. Best. Allowances for uncollectible amounts are established
 against reinsurance recoverables, if appropriate.

 American Southern's basic reinsurance treaties generally cover all claims in excess of specified per occurrence limitations.
 Limits per occurrence within the reinsurance treaties are as follows: Inland marine and commercial automobile physical damage - $ 225,000

 excess of $ 125,000 retention; and automobile liability and general liability - excess coverage of $ 2.0 million less retentions that may vary from $ 150,000

 to $ 500,000 depending on the account. American Southern maintains a property catastrophe treaty with a $ 5.5 million limit excess of $ 500,000
 retention. American Southern also issues individual surety bonds with face amounts generally up to $ 1.5 million, and limited to $ 5.0 million in aggregate per account, that are not reinsured.

 Bankers Fidelity has entered into reinsurance contracts ceding the excess of its life retention. Maximum retention by Bankers
 Fidelity on any one individual life insurance policyholder is $ 200,000. As of December 31, 2023, $ 8.3 million of the $ 814.2 million of
 life insurance in force at Bankers Fidelity was reinsured under a combination of coinsurance and yearly renewable term agreements. Certain prior year reinsurance agreements also remain in force although they no longer provide reinsurance for
 new business.

 Bankers Fidelity has also entered into a reinsurance contract ceding excess new Medicare Supplement business to General Re Life
 Corporation. Ceding thresholds are set annually. During 2023, the liability of the reinsurer was 50 % of all new Medicare Supplement
 business issued by the Company on amounts up to a maximum retention of $ 15.0 million of annualized premium. Accordingly, $ 0.8 million of the Company's $ 1.5
 million of new annualized Medicare Supplement premium was ceded.

 The

 effects of reinsurance on premiums written, premiums earned and insurance benefits and losses incurred were as follows:

 For the Year Ended December 31, 2023

 Total

 Direct premiums written

 $

 49,580

 $

 166,093

 $

 215,673

 Assumed premiums written

 27,987

 28,016

 Ceded premiums written

 ( 5,902

)

 ( 55,933

)

 ( 61,835

)

 Net premiums written

 $

 $

 110,189

 $

 181,854

 Direct premiums earned

 $

 46,349

 $

 166,368

 $

 212,717

 Assumed premiums earned

 27,996

 28,003

 Ceded premiums earned

 ( 5,902

)

 ( 55,993

)

 ( 61,895

)

 Net premiums earned

 $

 $

 $

 Provision for benefits and losses incurred

 $

 52,899

 $

 110,995

 $

 163,894

 Reinsurance loss recoveries

 ( 1,884

)

 ( 39,510

)

 ( 41,394

)

 $

 51,015

 $

 71,485

 $

 For the Year Ended December 31, 2022

 Total

 Direct premiums written

 $

 52,404

 $

 176,119

 $

 228,523

 Assumed premiums written

 26,814

 26,823

 Ceded premiums written

 ( 6,547

)

 ( 61,701

)

 ( 68,248

)

 Net premiums written

 $

 $

 114,427

 $

 187,098

 Direct premiums earned

 $

 51,844

 $

 176,995

 $

 228,839

 Assumed premiums earned

 24,978

 24,986

 Ceded premiums earned

 ( 6,546

)

 ( 61,839

)

 ( 68,385

)

 Net premiums earned

 $

 $

 $

 Provision for benefits and losses incurred

 $

 49,568

 $

 124,478

 $

 174,046

 Reinsurance loss recoveries

 ( 2,393

)

 ( 48,197

)

 ( 50,590

)

 $

 47,175

 $

 76,281

 $

 Components of reinsurance receivables at
 December 31, 2023 and 2022 were as follows:

 December 31, 2023

 Total

 Recoverable on unpaid losses, net of allowance

 $

 6,415

 $

 8,263

 $

 14,678

 Recoverable on unpaid benefits

 —

 5,470

 5,470

 Recoverable on paid losses

 —

 Ceded unearned premiums

 —

 Ceded advanced premiums

 —

 Total reinsurance receivables

 $

 6,415

 $

 14,688

 $

 21,103

 December 31, 2022

 Total

 Recoverable on unpaid losses

 $

 8,265

 $

 9,382

 $

 17,647

 Recoverable on unpaid benefits

 —

 6,788

 6,788

 Recoverable on paid losses

 —

 Ceded unearned premiums

 —

 Ceded advanced premiums

 —

 Total reinsurance receivables

 $

 8,265

 $

 17,648

 $

 25,913

 Note 8.

 Income Taxes

 Total income taxes were allocated as follows:

 2023

 2022

 Total tax expense (benefit) on income

 $

 ( 394

)

 $

 Tax expense (benefit) on components of shareholders' equity:

 Net unrealized income (losses) on investment securities

 1,602

 ( 10,589

)

 Total tax expense (benefit)

 $

 1,208

 $

 ( 10,018

)

 A reconciliation of the differences between income taxes computed at the federal statutory income tax rate and the income tax expense (benefit) is
 as follows:

 2023

 2022

 Federal income tax provision at the statutory rate

 $

 ( 119

)

 $

 Statutory rate

 %

 %

 Dividends-received deduction

 ( 24

)

 ( 24

)

 Meals and entertainment

 Vested stock and club dues

 Parking disallowance

 Penalties and fines

 —

 Adjustment for prior years' estimates to actual

 ( 299

)

 ( 86

)

 Income tax expense (benefit)

 $

 ( 394

)

 $

 Effective tax rate

 69.7

 %

 27.2

 %

 The primary difference between the effective tax rate and the federal statutory income tax rate for 2023 resulted from the adjustment for prior years' estimates to actual of $ 299 in the year ended December 31, 2023, which included the return to provision adjustment that is generally updated at the completion of the third
 quarter of each fiscal year and an adjustment for partnership valuation. Also contributing to the differences between the effective tax rate and the federal statutory income tax rate was a permanent difference related to meals and
 entertainment.

 The primary differences between the effective tax rate and the federal statutory income tax rate for 2022 resulted from a permanent difference related to penalties and fines
 incurred of $ 149. Also contributing to differences between the effective tax rate and the federal statutory income tax rate were the
 adjustment for prior years' estimates to actual that are generally updated at the completion of the third quarter of each fiscal year and were $ 86
 in the year ended December 31, 2022. Other contributing factors to the differences between the effective tax rate and the federal statutory income tax rate were permanent differences related to meals and entertainment and the dividends-received
 deduction ("DRD"). The current estimated DRD is adjusted as underlying factors change and can vary from estimates based on, but not limited to, actual distributions from investments as well as the amount of the Company's taxable income.

 Deferred tax assets and liabilities at December 31, 2023 and 2022 were comprised of the following:

 2023

 2022

 Deferred tax assets:

 Deferred acquisition costs

 $

 8,808

 $

 7,953

 Net unrealized investment losses

 3,342

 4,489

 Insurance reserves

 2,898

 1,597

 Impaired assets

 Bad debts and other

 Net operating loss

 —

 Total deferred tax assets

 16,735

 15,082

 Deferred tax liabilities:

 Deferred and uncollected premiums

 $

 ( 1,053

)

 $

 ( 835

)

 Net unrealized investment gains

 —

 —

 Other

 —

 ( 84

)

 Total deferred tax liabilities

 ( 1,053

)

 ( 919

)

 Net deferred tax asset

 $

 15,682

 $

 14,163

 The components of income tax expense (benefit) were:

 2023

 2022

 Current – Federal

 $

 2,727

 $

 2,390

 Deferred – Federal

 ( 3,121

)

 ( 1,819

)

 Total

 $

 ( 394

)

 $

 The Company has formal tax-sharing agreements, and files a consolidated income tax return, with its subsidiaries. Tax years 2020, 2021 and 2022 are considered open tax years that remain subject to examination by the Internal Revenue Service.

 Note 9.

 Credit Arrangements

 As

 expected, discontinuation of London Interbank Offered Rate ("LIBOR") occurred on June 30, 2023 ("LIBOR Cessation Date") and affected the rates used in the Company's credit arrangements after that date. On March 15, 2022, the U.S. Congress
 enacted the Adjustable Interest Rate LIBOR Act (the "LIBOR Act") to address LIBOR's cessation and to establish a clear and uniform process for replacing the overnight and one-, three-, six- and 12-month tenors of USD LIBOR in existing contracts
 that do not provide for the use of a clearly defined or practicable replacement benchmark rate ("tough legacy contracts"). Further, the Board of Governors of the Federal Reserve System issued regulations, 12 C.F.R. Part 253, "Regulations
 Implementing the Adjustable Interest Rate LIBOR Act (Regulation ZZ)," which relate to the LIBOR transition.

 Bank
 Debt

 On May 12, 2021, the Company entered into a Revolving Credit Agreement (the "Credit Agreement") with Truist Bank as the lender (the "Lender"). The Credit Agreement provides for
 an unsecured $ 10,000 revolving credit facility that matures on April 12, 2024. Prior to July 1, 2023, the Company paid interest on the unpaid principal balance of outstanding revolving loans at the 1 -month LIBOR Rate (as defined in the Credit Agreement) plus 2.00 %, subject to a LIBOR floor rate of 1.00 %. Effective July 1, 2023, the interest rate on the
 unpaid principal balance of outstanding revolving loans is determined based on a reference rate of the 1 -month Term Secured
 Overnight Financing Rate ("SOFR") published by Chicago Mercantile Exchange Group Benchmark Administration Limited ("CME") (as defined in the Credit Agreement) plus a spread adjustment of 0.11448 % plus 2.00 %, subject to a SOFR floor rate of 1.00 %.

 The Credit Agreement requires the Company to comply with certain covenants, including a debt to capital ratio that restricts the Company from incurring consolidated indebtedness
 that exceeds 35 % of the Company's consolidated capitalization at any time. The Credit Agreement also contains customary
 representations and warranties and events of default. Events of default include, among others, (a) the failure by the Company to pay any amounts owed under the Credit Agreement when due, (b) the failure to perform and not timely remedy
 certain covenants, (c) a change in control of the Company and (d) the occurrence of bankruptcy or insolvency events. Upon an event of default, the Lender may, among other things, declare all obligations under the Credit Agreement immediately
 due and payable and terminate the revolving commitments. As of December 31, 2023 and 2022, the Company had outstanding borrowings of $ 3,019 and $ 2,009, respectively, under the Credit Agreement.

 Junior Subordinated Debentures

 The Company has two unconsolidated
 Connecticut statutory business trusts, which exist for the exclusive purposes of: (i) issuing trust preferred securities ("Trust Preferred Securities") representing undivided beneficial interests in the assets of the trusts; (ii) investing the
 gross proceeds of the Trust Preferred Securities in junior subordinated deferrable interest debentures ("Junior Subordinated Debentures") of the Company; and (iii) engaging in those activities necessary or incidental thereto. At December 31,
 2023, the effective interest rate was 9.69 %.

 The outstanding $ 18.0 million and $ 15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are callable quarterly, in whole or in part, only at the option of the
 Company. Prior to July 1, 2023, the interest rate was based on 3 -month LIBOR plus an applicable margin. The margin ranges from 4.00 % to 4.10 %. Effective July 1,
 2023, the interest rate is determined based on a reference rate of the 3 -month SOFR plus applicable tenor spread of 0.26161 percent plus an applicable margin, ranging from 4.00 %
 to 4.10 %.

 The financial structure of each of Atlantic American Statutory Trust I and II, as of December 31, 2023 and 2022, was as follows:

 Atlantic American

 Statutory Trust I

 Atlantic American

 Statutory Trust II

 JUNIOR SUBORDINATED DEBENTURES (1)(2)

 Balance December 31, 2023

 $

 18,042

 $

 23,196

 Less: Treasury debt (3)

 —

 ( 7,500

)

 Net balance December 31, 2023

 $

 18,042

 $

 15,696

 Net balance December 31, 2022

 $

 18,042

 $

 15,696

 Coupon rate

 3-Month SOFR + 0.26161 spread adj + 4.00%

 3-Month SOFR + 0.26161 spread adj + 4.10%

 Interest payable

 Quarterly

 Quarterly

 Maturity date

 December 4, 2032

 May 15, 2033

 Redeemable by issuer

 Yes

 Yes

 TRUST PREFERRED SECURITIES

 Issuance date

 December 4, 2002

 May 15, 2003

 Securities issued

 17,500

 22,500

 Liquidation preference per security

 $

 $

 Liquidation value

 $

 17,500

 $

 22,500

 Coupon rate

 3-Month SOFR + 0.26161 spread adj + 4.00%

 3-Month SOFR + 0.26161 spread adj + 4.10%

 Distribution payable

 Quarterly

 Quarterly

 Distribution guaranteed by (4)

 Atlantic American Corporation

 Atlantic American Corporation

 (1)

 For each of the respective debentures, the Company has the right at any time, and from time to time, to defer
 payments of interest on the Junior Subordinated Debentures for a period not exceeding 20 consecutive quarters up to the
 debentures' respective maturity dates. During any such period, interest will continue to accrue and the Company may not declare or pay any cash dividends or distributions on, or purchase, the Company's common stock nor make any principal,
 interest or premium payments on or repurchase any debt securities that rank equally with or junior to the Junior Subordinated Debentures. The Company has the right at any time to dissolve each of the trusts and cause the Junior
 Subordinated Debentures to be distributed to the holders of the Trust Preferred Securities.

 (2)

 The Junior Subordinated Debentures are unsecured and rank junior and subordinate in right of payment to all
 senior debt of the Parent and are effectively subordinated to all existing and future liabilities of its subsidiaries.

 (3)

 In 2014, the Company acquired $ 7,500 of the Junior Subordinated Debentures.

 (4)

 The Parent has guaranteed, on a subordinated basis, all of the obligations under the Trust Preferred Securities,
 including payment of the redemption price and any accumulated and unpaid distributions to the extent of available funds and upon dissolution, winding up or liquidation.

 Note 10.

 Leases

 The Company has two operating
 lease agreements, each for the use of office space in the ordinary course of business. The first lease renews annually on an automatic basis and based on original assumptions, management is reasonably certain to exercise the renewal option
 through 2026. The original term of the second lease was ten years and amended in January 2017 to provide for an additional seven years, with a termination date on September 30, 2026. The rate used in determining the present value of lease payments is based upon an estimate
 of the Company's incremental secured borrowing rate commensurate with the term of the underlying lease.

 These leases are accounted for as operating leases, whereby lease expense is recognized on a straight-line basis over the term of the lease. Lease
 expense reported for each of the years ended December 31, 2023 and 2022 was $ 1,014.

 Additional information regarding the Company's real estate operating leases is as follows:

 Year Ended

 December 31, 2023

 Year Ended

 December 31, 2022

 Other information on operating leases:

 Cash payments included in the measurement of lease liabilities reported in operating cash flows

 $

 1,048

 1,031

 Right-of-use assets included in other assets on the consolidated
 balance sheet

 2,614

 3,405

 Weighted average discount rate

 6.8

 %

 6.8

 %

 Weighted average remaining lease term in years

 2.9 years

 3.9 years

 The following table presents maturities and present value of the Company's lease liabilities:

 Lease Liability

 2024

 $

 1,065

 2025

 1,083

 2026

 Thereafter

 —

 Total undiscounted lease payments

 3,090

 Less: present value adjustment

 Operating lease liability included in accounts payable and accrued expenses
 on the consolidated balance sheet

 $

 2,797

 As of December 31, 2023, the Company has no operating leases that have not yet commenced.

 Note 11.

 Benefit Plans

 Equity Incentive Plan

 On May 1, 2012, the
 Company's shareholders approved the 2012 Equity Incentive Plan (the "2012 Plan"). The 2012 Plan authorized the grant of up to 2,000,000
 stock options, stock appreciation rights, restricted shares, restricted stock units, performance shares, performance units and other awards for the purpose of providing the Company's non-employee directors, consultants, officers and other
 employees incentives and rewards for performance and service. The 2012 Plan expired on April 30, 2022, ten years after its effective
 date. As such, no grants have been or will be made under the 2012 Plan on or after its expiration, but outstanding awards granted
 thereunder will continue in accordance with their terms.

 On May 24, 2022, the Company's shareholders approved the 2022 Equity and Incentive Compensation Plan (the "2022 Plan"). The 2022 Plan authorizes the grant of up to 3,000,000 stock options, stock appreciation rights, restricted shares, restricted stock units, performance shares, performance units and other awards, and succeeded the 2012 Plan for the
 purpose of providing the Company's non-employee directors, consultants, officers and other employees incentives and rewards for performance and service.

 During the year ended 2023, there were no restricted shares issued under the 2022 Plan. During the year ended
 2022, a total of 40,000 restricted shares, with an estimated fair value of $ 122 were issued under the 2022 Plan, and a total of 25,000 restricted
 shares, with an estimated fair value of $ 71 were issued under the 2012 Plan. The estimated fair value of the restricted shares
 issued was based on the common stock price at date of grant. Stock grants are generally issued from treasury shares. Vesting of restricted shares generally occurs after a one to three year period following the date of grant. The Company accounts for
 forfeitures as they occur. There were no stock options granted or outstanding under the 2022 Plan in 2023 or 2022. There were no stock options granted or outstanding under the 2012 Plan in 2022.

 Shares available for future grant under the 2022 Plan at December 31, 2023 and 2022 were 2,960,000.

 401(k) Plan

 The Company initiated an employees' savings plan (the "Plan") qualified under Section 401(k) of the Internal Revenue Code in May 1995. The Plan
 covers substantially all of the Company's employees. Effective January 1, 2009, the Company modified the Plan such that the Plan would operate on a safe harbor basis. Under the Plan, employees may defer up to 50 % of their compensation, not to exceed the annual deferral limit. The Company's total matching contribution for 2023 and 2022 was $ 283 and $ 255, respectively, and consisted
 of a contribution equal to 35 % of up to the first 6 % of each participant's contributions. In addition to the matching contribution, the Company also provided a 3 %
 safe harbor non-elective contribution in 2023 and 2022 of $ 629 and $ 569, respectively. All contributions were made in cash. Participants are 100% vested in their own contributions and the vested percentage attributable to certain employer
 contributions is based on a five-year graded schedule.

 Agent Stock Purchase Plan

 The Company initiated a nonqualified stock purchase plan (the "Agent Stock Purchase Plan") in May 2012. The purpose of the Agent Stock Purchase Plan
 is to promote and advance the interests of the Company and its shareholders by providing independent agents who qualify as participants with an opportunity to purchase the common stock of the Company. Under the Agent Stock Purchase Plan, payment
 for shares of common stock of the Company is made by either deduction from an agent's commission payment or a direct cash payment. Stock purchases are made at the end of each calendar quarter at the then current market value.

 Note 12.

 Preferred Stock

 The Company had 55,000 shares
 of Series D preferred stock ("Series D Preferred Stock") outstanding at December 31, 2023 and 2022, respectively. All of the shares of Series D Preferred Stock are held by an affiliate of the Company's controlling shareholder. The outstanding
 shares of Series D Preferred Stock have a par value of $ 1 per share and a redemption value of $ 100 per share; accrue annual dividends at a rate of $ 7.25 per share (payable in cash or shares of the Company's common stock at the option of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of
 the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company's common stock,
 subject to certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000
 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company's option. The Series D Preferred Stock is not currently convertible. The Company had accrued, but unpaid, dividends, on the Series D
 Preferred Stock of $ 18 at December 31, 2023 and 2022. During each of 2023 and 2022, the Company paid Series D Preferred Stock
 dividends of $ 399.

 Note 13.

 Earnings Per Common Share

 Basic earnings per share was computed by dividing net income available to common shareholders by the weighted average number of common shares
 outstanding during the period. The computation of diluted earnings per share reflected the effect of potentially dilutive securities.

 A reconciliation of the numerator and denominator of the income per common share calculations is as follows:

 For the Year Ended December 31, 2023

 Income

 Weighted

 Average Shares

 Outstanding

 P er Share

 Basic and Diluted Loss Per Common Share

 Net loss before preferred stock dividends

 $

 ( 171

)

 20,404

 -

 Less preferred stock dividends

 ( 399

)

 —

 Net loss applicable to common shareholders

 $

 ( 570

)

 20,404

 $

 ( 0.03

)

 For the Year Ended December 31, 2022

 Income

 Weighted

 Average Shares

 Outstanding

 Per Share

 Basic and Diluted Earnings Per Common Share

 Net income before preferred stock dividends

 $

 1,525

 20,390

 -

 Less preferred stock dividends

 ( 399

)

 —

 Net income applicable to common shareholders

 $

 1,126

 20,390

 $

 0.06

 The assumed conversion of the Company's Series D Preferred Stock was excluded from the earnings per common share calculation for 2023 and 2022
 since its impact would have been antidilutive.

 Note 14.

 Statutory Reporting

 The assets, liabilities and results of operations have been reported on the basis of GAAP, which varies in some respects from statutory accounting
 practices ("SAP") prescribed or permitted by insurance regulatory authorities. The principal differences between SAP and GAAP are that under SAP: (i) carrying value of certain investments differ on a GAAP versus SAP basis, such as fixed
 maturities that are shown at amortized cost for SAP versus fair value for GAAP (ii) certain assets that are non-admitted assets are eliminated from the balance sheet; (iii) acquisition costs for policies are expensed as incurred, while they are
 deferred and amortized over the estimated life of the policies under GAAP; (iv) the provision that is made for deferred income taxes is different than under GAAP; (v) the timing and methodology of establishing certain reserves is different than
 under GAAP; (vi) reinsurance is shown net on balance sheet for SAP and (vii) certain valuation allowances attributable to certain investments are required under SAP such as asset valuation reserve and interest maintenance reserve.

 The Company meets the minimum capital requirements in the states in which it does business. The amount of reported statutory net income and
 capital and surplus (shareholders' equity) for the Parent's insurance subsidiaries for the years ended December 31 was as follows:

 2023

 2022

 Bankers Fidelity, net income

 $

 7,017

 $

 3,865

 American Southern, net income

 3,964

 5,743

 Statutory net income

 $

 10,981

 $

 9,608

 Bankers Fidelity, capital and surplus

 $

 38,299

 $

 36,672

 American Southern, capital and surplus

 51,774

 53,023

 Statutory capital and surplus

 $

 90,073

 $

 89,695

 Under the insurance code of the state in which each insurance subsidiary is domiciled, dividend payments to the Parent by its insurance
 subsidiaries are subject to certain limitations without the prior approval of the applicable state's Insurance Commissioner. The Parent received dividends of $ 8,400 and $ 7,200 in the years ended 2023 and 2022, respectively, from its
 subsidiaries. In 2024, dividend payments to the Parent by the insurance subsidiaries in excess of $ 8,757 would require prior approval.

 Note 15.

 Related Party Transactions

 In the normal course of business the Company has engaged in transactions with entities affiliated with the controlling shareholder of the Company.
 These transactions include the leasing of office space, certain investing and financing activities, as well as inconsequential administrative and consulting services. At December 31, 2023, two members of the Company's board of directors, including the Company's Chairman, President and Chief Executive Officer, were considered to be affiliates of the majority shareholder.

 The Company leases approximately 49,586
 square feet of office and covered garage space from one such controlled entity. During the years ended December 31, 2023 and 2022, the Company paid $ 1,199
 and $ 880, respectively, under this lease. In December 2022, Delta Life Insurance Company, the owner of the building, transferred
 title to the building to 4370 Peachtree LLC. Each of Delta Life Insurance Company and 4370 Peachtree LLC is controlled by an affiliate of the Company.

 Certain financing for the Company has also been provided by this entity in the form of an investment in the Series D Preferred Stock (See Note
 12). During the years ended December 31, 2023 and 2022, the Company paid this entity $ 399 in dividends on the Series D Preferred
 Stock.

 Certain members of the Company's management and board of directors are shareholders and on the board of directors of Gray Television, Inc.
 ("Gray"). As of December 31, 2023 and 2022, the Company owned 880,272 shares of Gray Class A common stock and 106,000 shares of Gray common stock. The aggregate carrying value of these investments in Gray at December 31, 2023 and 2022 was $ 8,490 and $ 10,772, respectively.

 In each of the years ended December 31, 2023 and 2022, Gray paid the Company approximately $ 2,050 and $ 1,708 in insurance premiums related to certain voluntary employee
 benefit plans.

 Note 16.

 Segment Information

 The Parent's primary insurance subsidiaries operate with relative autonomy and each company is evaluated based on its individual performance.
 American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. Each segment derives revenue from the collection of premiums, as well as from investment income.
 Substantially all revenue other than that in the corporate and other segment is from external sources.

 For the Year Ended December 31, 2023

 Corporate

 & Other

 Adjustments

 & Eliminations

 Consolidated

 Insurance premiums, net

 $

 $

 $

 —

 $

 —

 $

 51,015

 71,485

 —

 —

 Expenses deferred

 ( 8,689

)

 ( 9,320

)

 —

 —

 ( 18,009

)

 Amortization and depreciation expense

 8,389

 8,050

 —

 16,948

 Other expenses

 17,046

 39,262

 21,875

 ( 12,264

)

 65,919

 Total expenses

 67,761

 109,477

 22,384

 ( 12,264

)

 187,358

 Underwriting income

 —

 —

 1,587

 Net investment income (loss)

 4,507

 5,755

 3,325

 ( 3,529

)

 Other income (loss)

 8,738

 ( 8,735

)

 Subtotal

 5,196

 6,667

 ( 10,321

)

 —

 1,542

 Net realized gains

 —

 —

 —

 Unrealized losses on equity securities

 ( 111

)

 ( 2,015

)

 ( 51

)

 —

 ( 2,177

)

 $

 5,085

 $

 4,722

 $

 ( 10,372

)

 $

 —

 $

 ( 565

)

 Total revenues

 $

 72,846

 $

 114,199

 $

 12,012

 $

 ( 12,264

)

 $

 186,793

 Intangibles

 $

 1,350

 $

 1,194

 $

 —

 $

 —

 $

 2,544

 Total assets

 $

 149,236

 $

 203,079

 $

 146,585

 $

 ( 117,635

)

 $

 381,265

 For the Year Ended December 31, 2022

 Corporate

 & Other

 Adjustments

 & Eliminations

 Consolidated

 Insurance premiums, net

 $

 $

 $

 —

 $

 —

 $

 47,175

 76,281

 —

 —

 Expenses deferred

 ( 10,161

)

 ( 12,867

)

 —

 —

 ( 23,028

)

 Amortization and depreciation expense

 10,240

 9,452

 —

 20,190

 Other expenses

 20,082

 37,337

 17,432

 ( 9,714

)

 65,137

 Total expenses

 67,336

 110,203

 17,930

 ( 9,714

)

 185,755

 Underwriting income

 2,940

 4,961

 —

 —

 7,901

 Net investment income (loss)

 4,147

 5,414

 2,461

 ( 2,090

)

 9,932

 Other income (loss)

 7,624

 ( 7,624

)

 Subtotal

 7,090

 10,383

 ( 7,845

)

 —

 9,628

 Net realized gains (losses)

 ( 28

)

 —

 —

 Unrealized losses on equity securities

 ( 449

)

 ( 6,629

)

 ( 484

)

 —

 ( 7,562

)

 $

 6,613

 $

 3,812

 $

 ( 8,329

)

 $

 —

 $

 2,096

 Total revenues

 $

 73,949

 $

 114,015

 $

 9,601

 $

 ( 9,714

)

 $

 187,851

 Intangibles

 $

 1,350

 $

 1,194

 $

 —

 $

 —

 $

 2,544

 Total assets

 $

 144,455

 $

 195,028

 $

 140,661

 $

 ( 113,080

)

 $

 367,064

 Note 17.

 Commitments and Contingencies

 Litigation

 From time to time, the Company is, and expects to continue to be, involved in various claims and lawsuits incidental to and arising in the
 ordinary course of its business. In the opinion of management, any such known claims are not expected to have a material effect on the financial condition or results of operations of the Company.

 Regulatory Matters

 Like all domestic insurance companies, the Company's insurance subsidiaries are subject to regulation and supervision in the jurisdictions in
 which they do business. Statutes typically delegate regulatory, supervisory, and administrative powers to state insurance commissioners. From time to time, and in the ordinary course of business, the Company receives notices and inquiries from
 state insurance departments with respect to various matters. In the opinion of management, any such known regulatory matters are not expected to have a material effect on the financial condition or results of operations of the Company.

 Note 18.

 Subsequent Events

 On April 1, 2024, the Company announced that the board of directors declared an annual cash dividend of $ 0.02 per share of common stock that is payable to shareholders of record at the close of business on April 12, 2024.

 On March 22, 2024, the Company entered into a First Amendment (the "Amendment") to its Revolving Credit Agreement (as
 amended, the "Credit Agreement") with Truist Bank as the lender (the "Lender"). The Amendment, among other things, (a) updates the interest rate provisions to memorialize that the Company pays interest on the unpaid principal balance of
 outstanding revolving loans at the Adjusted Term SOFR rate (as defined in the Credit Agreement), plus 2.00 %, (b) extends the
 maturity date of the revolving credit facility to March 22, 2027 and (c) requires that the Company maintain a consolidated net
 worth of not less than $ 64.2 million. Except as modified by the Amendment, the existing terms of the Credit Agreement remain in
 effect.

 On February 21, 2024, a third-party service provider the Company utilizes for certain medical network claims data
 identified a cybersecurity incident, resulting in disruption of services. In response to the incident the Company examined our data and systems thoroughly and has not detected any breach of our systems. Subsequent to the incident, the
 Company transitioned to an alternative service provider as a permanent solution. We do not believe the cybersecurity incident at our third-party service provider materially affected or is reasonably likely to materially affect the Company
 or our business strategy, results of operations, or financial condition.

 Item 9.

 Changes in and Disagreements with Accountants on Accounting and Financial Disclosure

 None.

 Item 9A.

 Controls and Procedures

 Evaluation of Disclosure Controls and Procedures

 Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting for
 the Company. The Company's internal control over financial reporting system has been designed to provide reasonable assurance regarding the reliability and the preparation of financial statements for external purposes in accordance with
 generally accepted accounting principles. Management recognizes that there are inherent limitations in the effectiveness of any internal control system. Because of its inherent limitations, internal control over financial reporting may not
 prevent or detect all misstatements. Furthermore, the application of any evaluations of effectiveness on future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of
 compliance with the policies or procedures may deteriorate. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

 As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation
 of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the
 Securities Exchange Act of 1934). Based on that evaluation, management, including the Chief Executive Officer and Chief Financial Officer, concluded that disclosure controls and procedures were not effective as of that date due to a material
 weakness in internal control over financial reporting described below.

 Management's Report on Internal Control Over Financial Reporting

 Management assessed the effectiveness of the Company's internal control over financial reporting as of December 31, 2023 based
 upon the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in the updated 2013 Internal Control –
 Integrated Framework. Based on that evaluation, management believes that internal control over financial reporting as such term is
 defined in Exchange Act Rule 13a-15(f) was not effective as of December 31, 2023, as a result of the material weakness described below. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial
 reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.

 As a result of management's evaluation, we identified certain deficiencies in internal control that we believe rise to the level
 of a material weakness. Specifically, management determined that the design of the controls surrounding the process of reviewing insurance reserves and deferred acquisition costs within the Company's life and health segment was not effective.
 This deficiency in design did not enable the timely detection of anomalies in these values at the level of precision necessary to detect misstated values that may be material.

 Notwithstanding these deficiencies, management believes that, because of the actions taken by management in identifying, and to
 address and correct, these deficiencies prior to the completion and filing of this Annual Report on Form 10-K, and the effective operation of other internal controls over financial reporting, the material weakness did not result in any
 identified material misstatements to our financial statements. As a result, there were no changes to any of our historical financial statements.

 Attestation Report of the Registered Public Accounting Firm

 This Annual Report does not include an attestation report of the Company's independent registered public accounting firm regarding
 internal control over financial reporting. Management's report was not subject to attestation by the Company's independent registered public accounting firm pursuant to certain rules of the Securities and Exchange Commission that exempt
 non-accelerated filers, including the Company, from such requirement.

 Changes in Internal Control Over Financial Reporting

 There were no changes in the Company's internal control over financial reporting during the quarter ended December 31, 2023 that
 have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

 The Company is currently in the process of remediating the material weakness as described above, which remediation efforts began
 in the quarter ended March 31, 2024 and include developing and implementing enhanced controls related to the review of values that are estimated using actuarial models. The enhancements include implementing reviews at the product level where
 management evaluates, for each of the Company's life and health products, the components of underwriting income and how they interrelate. In addition, calculations that are independent from the actuarial models will, once fully developed,
 validate that the product parameters and actuarial assumptions are completely and accurately reflected within the actuarial models.

 The Company has also initiated the development of an array of analytical reports that will help facilitate the timely detection of
 anomalous values within the Company's life and health segment. It is currently expected that these reports will be operational by September 30, 2024. These reports will include reconciliations of actuarial values from quarter to quarter,
 utilizing values estimated via the actuarial models and values that are produced by accounting processes.

 Inherent Limitations on Effectiveness of Controls

 No system of controls, no matter how well designed and implemented, can provide absolute assurance that the objectives of the
 system of controls are met. Furthermore, no evaluation of controls can provide absolute assurance that all control issues and any instances of fraud within a company have been detected.

 Item 9B.

 Other Information

 None of the Company's directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the quarter ended December 31, 2023, as such
 terms are defined under Item 408(a) of Regulation S-K.

 Item 9C.

 Disclosure Regarding Foreign Jurisdictions that Prevent Inspections

 Not applicable.

 With the exception of certain information relating to the executive officers of the Company, which is provided in Part I hereof, the information relating to securities authorized for issuance
 under equity compensation plans and the information relating to the Company's Code of Business Conduct and Ethics, each of which is included below, all information required by Part III (Items 10, 11, 12, 13 and 14 of Form 10-K) is
 incorporated by reference to the sections entitled "Election of Directors," "Security Ownership of Certain Beneficial Owners and Management," "Delinquent Section 16(a) Reports" (if applicable), "Executive Compensation," "Certain Relationships
 and Related Person Transactions" and "Ratification of the Appointment of the Company's Independent Registered Public Accounting Firm" to be contained in the Company's definitive proxy statement in connection with the Company's 2024 Annual
 Meeting of Shareholders, to be filed with the SEC within 120 days of the Company's fiscal year end.

 Equity Compensation Plan Information

 The following table sets forth, as of December 31, 2023, the number of securities issuable upon exercise of outstanding options, warrants and rights, the weighted average exercise price
 thereof and the number of securities remaining available for future issuance under the Company's equity compensation plans:

 Plan Category

 Securities to Be

 Issued Upon

 Exercise of

 Outstanding

 Options,

 Warrants

 and Rights

 Weighted-Average

 Exercise Price

 of Outstanding

 Options,

 Warrants

 and Rights

 Number of Securities

 Remaining Available

 for Future Issuance

 Under Equity

 Compensation Plans

 (Excluding Securities

 Reflected in the

 First Column)

 Equity compensation plans approved by security holders

 —

 $

 —

 2,960,000

 Equity compensation plans not approved by security holders (1)

 —

 —

 —

 Total

 —

 $

 —

 2,960,000

 (1)

 All of the Company's equity compensation plans have been approved by the Company's shareholders.

 Code of Business Conduct and Ethics

 The Company has adopted a Code of Business Conduct and Ethics that applies to its principal executive officer, principal financial officer, principal accounting officer or controller, or any
 persons performing similar functions, as well as its directors and other employees. A copy of this Code of Business Conduct and Ethics has been filed as an exhibit to this annual report on Form 10-K.

 Item 15.

 Exhibits and Financial Statement Schedules

 (a)

 List of documents filed as part of this report:

 1.

 Financial Statements:

 See Index to Financial Statements contained in Item 8 hereof.

 2.

 Financial Statement Schedules:

 Schedule II - Condensed financial information of the registrant

 Schedule III - Supplementary insurance information of the registrant

 Schedule IV - Reinsurance information for the registrant

 Schedule VI - Supplemental information concerning property-casualty insurance operations of the registrant

 Schedules other than those listed above are omitted as they are not required or are not applicable, or the required information is shown in the financial statements or notes thereto. Columns omitted from
 schedules filed have been omitted because the information is not applicable.

 3.

 Exhibits *:

 3.1

 Restated Articles of Incorporation of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant's Form 10-K for the year ended December 31, 2008].

 3.2

 Restated Bylaws of the registrant, as amended [incorporated by reference to Exhibit 3.1 to the registrant's Form 8-K filed on March 4, 2016].

 4.1

 Description of the registrant's common stock registered pursuant to section 12 of the Securities Exchange Act of 1934 [incorporated by reference to Exhibit 4.1 to the registrant's Form 10-K filed on
 March 24, 2020].

 10.01

 Management Agreement, dated July 1, 1993, between the registrant and Atlantic American Life Insurance Company and Bankers Fidelity Life Insurance Company [incorporated by reference to Exhibit 10.41 to
 the registrant's Form 10-Q for the quarter ended September 30, 1993].

 10.02

 Tax Allocation Agreement, dated as of January 4, 2016, between the registrant and the registrant's subsidiaries [incorporated by reference to Exhibit 10.02 to the registrant's Form 10-K for the year
 ended December 31, 2017].

 10.03**

 Atlantic American Corporation 2012 Nonqualified Stock Purchase Plan [incorporated by reference to Exhibit 99.1 to the registrant's Form S-8 (File No. 333-183207) filed on August 10, 2012].

 10.04**

 Atlantic American Corporation 2012 Equity Incentive Plan [incorporated by reference to Exhibit 10.1 to the registrant's Form 10-Q for the quarter ended March 31, 2013].

 10.05

 Lease Agreement, dated as of November 1, 2007, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation and Delta Life Insurance Company
 [incorporated by reference to Exhibit 10.10 to the registrant's Form 10-K for the year ended December 31, 2007].

 10.06

 First Amendment to Lease Agreement, dated as of March 31, 2008, between Georgia Casualty & Surety Company, Bankers Fidelity Life Insurance Company, Atlantic American Corporation and Delta Life
 Insurance Company [incorporated by reference to Exhibit 10.2 to the registrant's Form 10-Q for the quarter ended March 31, 2008].

 10.07

 Assignment and Assumption of Leases and Contracts, dated as of December 21, 2022, by and between Delta Life Insurance Company and 4370 Peachtree LLC.

 10.09

 Revolving Credit Agreement, dated as of May 12, 2021, by and between Atlantic American Corporation and Truist Bank [incorporated by reference to Exhibit 10.1 to the registrant's Form 8-K filed with the
 SEC on May 13, 2021].

 10.10**

 Atlantic American Corporation 2022 Equity and Incentive Compensation Plan [incorporated by reference to Exhibit 10.1 to the registrant's Form 8-K filed on May 31, 2022].

 14.1

 Code of Business Conduct and Ethics [incorporated by reference to Exhibit 14.1 to the registrant's Form 10-K for the year ended December 31, 2003].

 21.1

 Subsidiaries of the registrant [incorporated by reference to Exhibit 21.1 to the registrant's Form 10-K for the year ended December 31, 2015].

 23.1

 Consent of FORVIS LLP, Independent Registered Public Accounting Firm.

 31.1

 Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 31.2

 Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

 32.1

 Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

 97.1

 Atlantic American Corporation Compensation Clawback Policy

 101.INS

 101.SCH

 101.CAL

 101.DEF

 101.LAB

 101.PRE

 *

 The registrant agrees to furnish to the Commission upon request a copy of any instruments defining the rights of security holders of the registrant that may be omitted from filing in accordance with the Commission's rules and
 regulations.

 **

 Management contract, compensatory plan or arrangement.

 Item 16.

 Form 10-K Summary

 None.

 SIGNATURES

 Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto
 duly authorized.

 (Registrant)

 By:

 /s/ J. Ross Franklin

 J. Ross Franklin

 Vice President and Chief Financial Officer

 Date: April 1, 2024

 Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the
 dates indicated.

 Signature

 Title

 Date

 /s/ Hilton H. Howell, Jr.

 President, Chief Executive Officer and Chairman of the Board

 (Principal Executive Officer)

 HILTON H. HOWELL, JR.

 /s/ J. Ross Franklin

 Vice President and Chief Financial Officer

 (Principal Financial and Accounting Officer)

 J. ROSS FRANKLIN

 /s/ Robin R. Howell

 ROBIN R. HOWELL

 /s/ Mark E. Preisinger

 MARK E. PREISINGER

 /s/ Joseph M. Scheerer

 JOSEPH M. SCHEERER

 /s/ Scott G. Thompson

 SCOTT G. THOMPSON

 /s/ D. Keehln Wheeler

 D. KEEHLN WHEELER

 Schedule II

 Page 1 of 3

 CONDENSED FINANCIAL INFORMATION OF REGISTRANT

 (Parent Company Only)

 BALANCE SHEETS

 ASSETS

 December 31,

 2023

 2022

 Cash and cash equivalents

 $

 2,774

 $

 2,680

 1,930

 2,278

 Investment in subsidiaries

 117,637

 113,079

 Investments in unconsolidated trusts

 1,238

 1,238

 Deferred tax asset, net

 15,682

 14,163

 Income taxes receivable from subsidiaries

 1,988

 1,951

 Other assets

 6,733

 6,681

 Total assets

 $

 147,982

 $

 142,070

 LIABILITIES AND SHAREHOLDERS' EQUITY

 Other payables

 $

 3,949

 $

 4,130

 Revolving credit facility

 3,019

 2,009

 Junior subordinated debentures

 Total liabilities

 40,706

 39,877

 Shareholders' equity

 107,276

 102,193

 Total liabilities and shareholders' equity

 $

 147,982

 $

 142,070

 Schedule II

 Page 2 of 3

 CONDENSED FINANCIAL INFORMATION OF REGISTRANT

 (Parent Company Only)

 STATEMENTS OF OPERATIONS

 2023

 2022

 Revenue

 Fee income from subsidiaries

 $

 8,738

 $

 7,624

 Distributed earnings from subsidiaries

 8,400

 7,200

 ( 51

)

 ( 484

)

 Other

 ( 455

)

 Total revenue

 16,632

 14,433

 General and administrative expenses

 15,336

 13,583

 Interest expense

 3,269

 1,952

 ( 1,973

)

 ( 1,102

)

 Income tax benefit (1)

 ( 4,802

)

 ( 3,934

)

 2,829

 2,832

 Equity in undistributed earnings of subsidiaries, net

 ( 3,000

)

 ( 1,307

)

 $

 ( 171

)

 $

 1,525

 (1)

 Under the terms of a tax-sharing agreement, income tax provisions for the subsidiary companies are computed on a separate company
 basis. Accordingly, the Company's income tax benefit results from the utilization of the Parent's separate return loss to reduce the consolidated taxable income of the Company.

 Schedule II

 Page 3 of 3

 CONDENSED FINANCIAL INFORMATION OF REGISTRANT

 (Parent Company Only)

 STATEMENTS OF CASH FLOWS

 2023

 2022

 Cash flows from operating activities:

 Net Income (loss)

 $

 ( 171

)

 $

 1,525

 Adjustments to reconcile net income to net cash used in operating activities:

 Depreciation and amortization

 Compensation expense related to share awards

 Loss (earnings) from equity method investees

 ( 294

)

 Equity in undistributed earnings of subsidiaries, net

 3,000

 1,307

 (Increase) decrease in intercompany taxes

 ( 37

)

 Deferred income tax benefit

 ( 3,123

)

 ( 2,336

)

 Decrease in accounts payable and accrued expenses

 ( 181

)

 ( 285

)

 Other, net

 ( 509

)

 ( 1,348

)

 Net cash used in operating activities

 ( 48

)

 ( 78

)

 Cash flows from investing activities:

 Additions to property and equipment

 ( 39

)

 ( 45

)

 Net cash used in investing activities

 ( 39

)

 ( 45

)

 Cash flows from financing activities:

 Payment of dividends on Series D preferred stock

 ( 399

)

 ( 399

)

 Payment of dividends on common stock

 ( 408

)

 ( 408

)

 Proceeds from revolving credit facility, net

 1,000

 2,000

 Treasury stock acquired — net employee share-based compensation

 ( 12

)

 ( 108

)

 Net cash provided by financing activities

 1,085

 Net increase in cash

 Cash and cash equivalents at beginning of year

 2,680

 1,718

 Cash and cash equivalents at end of year

 $

 2,774

 $

 2,680

 Supplemental disclosure:

 Cash paid for interest

 $

 3,227

 $

 1,794

 Cash paid for income taxes

 $

 2,582

 $

 2,764

 Intercompany tax settlement from subsidiaries

 $

 4,031

 $

 3,946

 Schedule III

 Page 1 of 2

 ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES

 SUPPLEMENTARY INSURANCE INFORMATION

 Segment

 Deferred

 Acquisition

 Costs

 Future Policy

 Benefits,

 Losses,

 Claims and

 Loss

 Unearned

 Other Policy

 Claims and

 Benefits

 Payable

 December 31, 2023:

 $

 41,150

 $

 116,141

 $

 2,561

 $

 1,132

 2,700

 63,832

 28,756

 —

 $

 43,850

 $

 179,973

 (1)

 $

 31,317

 $

 1,132

 December 31, 2022:

 $

 39,880

 $

 110,238

 $

 2,814

 $

 1,255

 2,401

 62,810

 25,534

 —

 $

 42,281

 $

 173,048

 (2)

 $

 28,348

 $

 1,255

 (1)

 Includes future policy benefits of $ 92,495
 and losses and claims of $ 87,478.

 (2)

 Includes future policy benefits of $ 85,564
 and losses and claims of $ 87,484.

 Schedule III

 Page 2 of 2

 ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES

 SUPPLEMENTARY INSURANCE INFORMATION

 Segment

 Premium

 Revenue

 Net

 Investment

 Income (Loss)

 Benefits,

 Claims,

 Losses and

 Settlement

 Expenses

 Amortization

 of Deferred

 Acquisition

 Costs

 Other

 Operating

 Expenses

 Casualty

 Written

 December 31, 2023:

 $

 $

 5,755

 $

 71,485

 $

 8,050

 $

 29,942

 $

 —

 4,507

 51,015

 8,390

 8,356

 Corporate & other

 —

 ( 204

)

 —

 —

 10,120

 —

 $

 $

 $

 $

 16,440

 $

 48,418

 $

 December 31, 2022:

 $

 $

 5,414

 $

 76,281

 $

 9,295

 $

 24,627

 $

 —

 4,147

 47,175

 10,150

 10,011

 Corporate & other

 —

 —

 —

 8,216

 —

 $

 $

 9,932

 $

 $

 19,445

 $

 42,854

 $

 Schedule IV

 ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES

 REINSURANCE INFORMATION

 Direct

 Ceded to

 Other

 Companies

 Assumed

 From Other

 Companies

 Net

 Amounts

 Percentage

 of Amount

 Assumed

 to Net

 Year ended December 31, 2023:

 Life insurance in force

 $

 814,241

 $

 ( 8,317

)

 $

 —

 $

 805,924

 Premiums —

 $

 166,368

 $

 ( 55,993

)

 $

 $

 0.0

 %

 46,349

 ( 5,902

)

 27,996

 40.9

 %

 Total premiums

 $

 212,717

 $

 ( 61,895

)

 $

 28,003

 $

 15.7

 %

 Year ended December 31, 2022:

 Life insurance in force

 $

 670,610

 $

 ( 9,597

)

 $

 —

 $

 661,013

 Premiums —

 $

 176,995

 $

 ( 61,839

)

 $

 $

 0.0

 %

 51,844

 ( 6,546

)

 24,978

 35.5

 %

 Total premiums

 $

 228,839

 $

 ( 68,385

)

 $

 24,986

 $

 13.5

 %

 Schedule VI

 ATLANTIC AMERICAN CORPORATION AND SUBSIDIARIES

 SUPPLEMENTAL INFORMATION CONCERNING

 PROPERTY-CASUALTY INSURANCE OPERATIONS

 Claims and Claim

 Adjustment

 Expenses Incurred

 Related To

 Year Ended

 Deferred

 Policy

 Acquisition

 Costs

 Unearned

 Earned

 Net

 Investment

 Income

 Current

 Year

 Prior

 Years

 Amortization

 of Deferred

 Acquisition

 Costs

 Paid Claims

 and Claim

 Adjustment

 Expenses

 Written

 December 31, 2023

 $

 2,700

 $

 63,832

 $

 28,756

 $

 $

 4,507

 $

 47,658

 $

 3,357

 $

 8,390

 $

 48,144

 $

 December 31, 2022

 $

 2,401

 $

 62,810

 $

 25,534

 $

 $

 4,147

 $

 48,692

 $

 ( 1,517

)

 $

 10,150

 $

 42,948

 $